<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9815831</journal-id>
<journal-id journal-id-type="pubmed-jr-id">22061</journal-id>
<journal-id journal-id-type="nlm-ta">Genet Med</journal-id>
<journal-id journal-id-type="iso-abbrev">Genet. Med.</journal-id>
<journal-title-group>
<journal-title>Genetics in medicine : official journal of the American College of Medical Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1098-3600</issn>
<issn pub-type="epub">1530-0366</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30158690</article-id>
<article-id pub-id-type="pmc">6395558</article-id>
<article-id pub-id-type="doi">10.1038/s41436-018-0085-6</article-id>
<article-id pub-id-type="manuscript">NIHMS973104</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Clinical exome sequencing reveals locus heterogeneity and phenotypic variability of cohesinopathies</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yuan</surname>
<given-names>Bo</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Neira</surname>
<given-names>Juanita</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A26">26</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pehlivan</surname>
<given-names>Davut</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Santiago-Sim</surname>
<given-names>Teresa</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Song</surname>
<given-names>Xiaofei</given-names>
</name>
<degrees>BS</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rosenfeld</surname>
<given-names>Jill</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Posey</surname>
<given-names>Jennifer E.</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Patel</surname>
<given-names>Vipulkumar</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jin</surname>
<given-names>Weihong</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Adam</surname>
<given-names>Margaret P.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Baple</surname>
<given-names>Emma L.</given-names>
</name>
<degrees>MBBS, PhD</degrees>
<xref ref-type="aff" rid="A7">7</xref>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dean</surname>
<given-names>John</given-names>
</name>
<degrees>FRCP</degrees>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fong</surname>
<given-names>Chin-To</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hickey</surname>
<given-names>Scott E.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hudgins</surname>
<given-names>Louanne</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A12">12</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Leon</surname>
<given-names>Eyby</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A13">13</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Madan-Khetarpal</surname>
<given-names>Suneeta</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A14">14</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rawlins</surname>
<given-names>Lettie</given-names>
</name>
<degrees>MBChB</degrees>
<xref ref-type="aff" rid="A7">7</xref>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rustad</surname>
<given-names>Cecilie F.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A15">15</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stray-Pedersen</surname>
<given-names>Asbjørg</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A16">16</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tveten</surname>
<given-names>Kristian</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A17">17</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wenger</surname>
<given-names>Olivia</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A18">18</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Diaz</surname>
<given-names>Jullianne</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="A13">13</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jenkins</surname>
<given-names>Laura</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="A14">14</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Martin</surname>
<given-names>Laura</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="A10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McGuire</surname>
<given-names>Marianne</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pietryga</surname>
<given-names>Marguerite</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="A11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ramsdell</surname>
<given-names>Linda</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Slattery</surname>
<given-names>Leah</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="A12">12</xref>
</contrib>
<contrib contrib-type="author">
<collab>DDD Study</collab>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Abid</surname>
<given-names>Farida</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bertuch</surname>
<given-names>Alison</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Grange</surname>
<given-names>Dorothy</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A19">19</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Immken</surname>
<given-names>LaDonna</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A20">20</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schaaf</surname>
<given-names>Christian P.</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A21">21</xref>
<xref ref-type="aff" rid="A22">22</xref>
<xref ref-type="aff" rid="A23">23</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Van Esch</surname>
<given-names>Hilde</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A24">24</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bi</surname>
<given-names>Weimin</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cheung</surname>
<given-names>Sau Wai</given-names>
</name>
<degrees>PhD, MBA</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Breman</surname>
<given-names>Amy M.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Smith</surname>
<given-names>Janice L.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shaw</surname>
<given-names>Chad</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Crosby</surname>
<given-names>Andrew H.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eng</surname>
<given-names>Christine</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Yaping</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lupski</surname>
<given-names>James R.</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A25">25</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xiao</surname>
<given-names>Rui</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Pengfei</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1.</label>Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA</aff>
<aff id="A2"><label>2.</label>Baylor Genetics, Houston, TX 77021, USA</aff>
<aff id="A3"><label>3.</label>Texas Children’s Hospital, Houston, TX 77030, USA</aff>
<aff id="A4"><label>4.</label>Section of Child Neurology, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA</aff>
<aff id="A5"><label>5.</label>Seattle Children’s Hospital, Seattle, WA 98105, USA</aff>
<aff id="A6"><label>6.</label>Department of Pediatrics, University of Washington School of Medicine, Seattle, WA 98105, USA</aff>
<aff id="A7"><label>7.</label>University of Exeter Medical School, RILD Wellcome Wolfson Centre, Royal Devon &amp; Exeter NHS Foundation Trust, Barrack Road, Exeter, EX2 5DW, UK</aff>
<aff id="A8"><label>8.</label>Peninsula Clinical Genetics Service, Royal Devon &amp; Exeter Hospital, Gladstone Road, Exeter, EX1 2ED, UK</aff>
<aff id="A9"><label>9.</label>Clinical Genetics Service, NHS Grampian, Aberdeen, AB25 2ZA, Scotland</aff>
<aff id="A10"><label>10.</label>Department of Pediatrics, University of Rochester Medical Center, Rochester, NY 14642, USA</aff>
<aff id="A11"><label>11.</label>Department of Pediatrics, Nationwide Children’s Hospital, Columbus, OH 43205, USA</aff>
<aff id="A12"><label>12.</label>Division of Medical Genetics, Stanford University, Stanford, CA 94305, USA</aff>
<aff id="A13"><label>13.</label>Rare Disease Institute, Children’s National Health System, Washington, DC 20010, USA</aff>
<aff id="A14"><label>14.</label>Children’s Hospital of Pittsburgh of UPMC, Pittsburgh PA 15224, USA</aff>
<aff id="A15"><label>15.</label>Department of medical genetics, Oslo University Hospital, 0424 Oslo, Norway</aff>
<aff id="A16"><label>16.</label>Norwegian National Unit for Newborn Screening, Division of Pediatric and Adolescent Medicine, Oslo University Hospital, 0424 Oslo, Norway</aff>
<aff id="A17"><label>17.</label>Department of Medical Genetics, Telemark Hospital Trust, 3710 Skien, Norway</aff>
<aff id="A18"><label>18.</label>New Leaf Center, clinic for special children, Mt. Eaton, OH 44659, USA</aff>
<aff id="A19"><label>19.</label>Division of Genetics and Genomic Medicine, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110</aff>
<aff id="A20"><label>20.</label>Dell Children’s Medical Center of Central Texas, Austin, TX 78723, USA</aff>
<aff id="A21"><label>21.</label>Institute of Human Genetics, University Hospital Cologne, Cologne, Germany</aff>
<aff id="A22"><label>22.</label>Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany</aff>
<aff id="A23"><label>23.</label>Center for Rare Diseases, University Hospital Cologne, Cologne, Germany</aff>
<aff id="A24"><label>24.</label>Center for Human Genetics, Department of Human Genetics, KU Leuven, 3000 Leuven, Belgium</aff>
<aff id="A25"><label>25.</label>Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA</aff>
<aff id="A26"><label>26.</label>Current address: Emory University, Department of Human Genetics, Atlanta, GA 30322, USA</aff>
<author-notes>
<corresp id="CR1">Corresponding Author: Pengfei Liu, PhD, FACMG, Assistant Professor of Department of Molecular and Human Genetics, Assistant Director of Baylor Genetics, Baylor College of Medicine, 713-798-5122, <email>pengfei.liu@bcm.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>15</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>30</day>
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>07</day>
<month>3</month>
<year>2019</year>
</pub-date>
<volume>21</volume>
<issue>3</issue>
<fpage>663</fpage>
<lpage>675</lpage>
<!--elocation-id from pubmed: 10.1038/s41436-018-0085-6-->
<permissions>
<license xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms">
<license-p>Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:<ext-link ext-link-type="uri" xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms">http://www.nature.com/authors/editorial_policies/license.html#terms</ext-link></license-p>
</license>
</permissions>
<abstract id="ABS1">
<sec id="S1">
<title>Purpose:</title>
<p id="P1">Defects in the cohesin pathway are associated with cohesinopathies, notably Cornelia de Lange Syndrome (CdLS). We aim to delineate mutations in known and candidate cohesinopathy genes from a clinical exome perspective.</p>
</sec>
<sec id="S2">
<title>Methods:</title>
<p id="P2">We retrospectively studied patients referred for clinical exome sequencing (CES, N=10,698). Patients with causative variants in novel or recently described cohesinopathy genes were enrolled for phenotypic characterization.</p>
</sec>
<sec id="S3">
<title>Results:</title>
<p id="P3">Pathogenic or likely pathogenic single nucleotide and insertion/deletion variants (SNVs/indels) were identified in established disease genes including <italic>NIPBL</italic> (N=5), <italic>SMC1A</italic> (N=14), <italic>SMC3</italic> (N=4), <italic>RAD21</italic> (N=2) and <italic>HDAC8</italic> (N=8). The phenotypes in this genetically defined cohort skew towards the mild end of CdLS spectrum as compared to phenotype-driven cohorts. Candidate or recently reported cohesinopathy genes were supported by <italic>de novo</italic> SNVs/indels in <italic>STAG1</italic> (N=3), <italic>STAG2</italic> (N=5), <italic>PDS5A</italic> (N=1) and <italic>WAPL</italic> (N=1), and one inherited SNV in <italic>PDS5A</italic>. We also identified copy number deletions affecting <italic>STAG1</italic> (two <italic>de novo</italic>, one of unknown inheritance) and <italic>STAG2</italic> (one of unknown inheritance). Patients with <italic>STAG1</italic> and <italic>STAG2</italic> variants presented with overlapping features yet without characteristic facial features of CdLS.</p>
</sec>
<sec id="S4">
<title>Conclusion:</title>
<p id="P4">CES effectively identified disease-causing alleles at the mild end of the cohensinopathy spectrum and enabled characterization of candidate disease genes.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Atypical cohesinopathies</kwd>
<kwd>clinical exome sequencing (CES)</kwd>
<kwd>cohesin pathway</kwd>
<kwd>
<italic>STAG1</italic>
</kwd>
<kwd>
<italic>STAG2</italic>
</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="S5">
<title>INTRODUCTION</title>
<p id="P5">The cohesin complex mediates sister chromatid cohesion and ensures accurate chromosome segregation, recombination-mediated DNA repair, and genomic stability during DNA replication and cell division. Accumulating evidence suggests that cohesin is also involved in regulating chromosomal looping/architecture and gene transcriptional regulation<sup><xref ref-type="bibr" rid="R1">1</xref>–<xref ref-type="bibr" rid="R3">3</xref></sup>.</p>
<p id="P6">Cohesin is a multi-subunit protein complex composed of evolutionarily conserved core components encoded by <italic>SMC1A</italic> (MIM *300040), <italic>SMC3</italic> (MIM *606062), <italic>RAD21</italic> (MIM *606462) and either <italic>STAG1</italic> (MIM *604358) or <italic>STAG2</italic> (MIM *300826) depending on the chromosomal location. Direct interaction between SMC1A, SMC3 and RAD21 form a tripartite ring structure that is used to entrap the replicated chromatin during sister chromatid cohesion (<xref ref-type="fig" rid="F1">Figure 1A</xref>). STAG1/2 are the core structural component of functional cohesin and critical for the loading of cohesin onto chromatin during mitosis<sup><xref ref-type="bibr" rid="R1">1</xref>,<xref ref-type="bibr" rid="R2">2</xref></sup>.</p>
<p id="P7">In addition to the aforementioned structural components, cohesin also interacts with the regulatory factors of the cohesion cycle, including proteins encoded by <italic>NIPBL</italic> (MIM *608667), <italic>MAU2</italic> (MIM *614560), <italic>PDS5A</italic> (MIM *613200) or <italic>PDS5B</italic> (MIM *605333), <italic>WAPL</italic> (MIM *610754), <italic>HDAC8</italic> (MIM *300269), <italic>ESCO1</italic> (MIM *609674), and <italic>ESCO2</italic> (MIM *609353), to facilitate cohesin dynamics and function on chromatin (<xref ref-type="fig" rid="F1">Figure 1A</xref>)<sup><xref ref-type="bibr" rid="R1">1</xref>,<xref ref-type="bibr" rid="R2">2</xref></sup>.</p>
<p id="P8">Precise orchestration of cohesin’s structural components and regulatory factors ensures faithful progression of the cohesion cycle (<xref ref-type="fig" rid="F1">Figure 1A</xref>). Defects of the structural or regulatory components of cohesin lead to various multisystem malformation syndromes described as “cohesinopathies”, a collection of syndromes with shared clinical findings such as distinctive facial features, growth retardation, developmental delay/intellectual disability (DD/ID), and limb abnormalities. Clinically, the most distinguishable type of cohesinopathy is the classic Cornelia de Lange Syndrome (CdLS, MIM# 122470), with the majority of cases explained by SNVs/indels and exonic deletion copy number variants (CNVs) resulting in loss-of-function (LoF) alleles in <italic>NIPBL</italic><sup><xref ref-type="bibr" rid="R4">4</xref>–<xref ref-type="bibr" rid="R6">6</xref></sup>. The traditional phenotype-driven studies that included the mild end of the CdLS spectrum led to the discovery of <italic>SMC1A, SMC3, RAD21</italic> and <italic>HDAC8</italic> (MIM# 122470, 300590, 610759, 614701 and 300882) as new cohesinopathy genes <sup><xref ref-type="bibr" rid="R4">4</xref>–<xref ref-type="bibr" rid="R11">11</xref></sup>. The resultant CdLS phenotype is largely dependent on the genes being affected and mutation types<sup><xref ref-type="bibr" rid="R12">12</xref></sup>. Although mild forms of CdLS present with less striking phenotypes and are more clinically challenging to recognize in comparison to the classic form, they have been found in an increasing number of patients with cohesinopathies.</p>
<p id="P9">Here, we used a genotype-driven approach to investigate the allelic series of genes encoding cohesin components based on a large cohort of patients (N=10,698) with a variety of unselected clinical presentations who were referred for clinical exome sequencing (CES). We identified pathogenic or likely pathogenic variants in known CdLS genes (<italic>NIPBL, SMC1A, SMC3, RAD21</italic>, and <italic>HDAC8</italic>) in patients mostly without a clinical diagnosis of CdLS, representing a cohort on the mild end of the clinical presentation of cohesinopathies. By applying the same genotype-first approach in the CES cohort, we further established <italic>STAG1</italic> and <italic>STAG2</italic> as new cohesinopathy genes with variants that act by a putative LoF mechanism, corroborating recent reports of patients with developmental disorders carrying mutations in these two genes<sup><xref ref-type="bibr" rid="R13">13</xref>–<xref ref-type="bibr" rid="R15">15</xref></sup>. Additional studies of patients who had chromosome microarray analyses (CMA, N=63,127) also identified deletion CNVs affecting <italic>STAG1</italic> and <italic>STAG2</italic>, which further supports the human disease association of these two genes via a LoF mechanism. We also provide evidence supporting the candidacy of <italic>PDS5A</italic> and <italic>WAPL</italic> as cohesinopathy disease genes. Our findings emphasize the utility of using CES to provide molecular diagnoses for disorders with extensive genetic and phenotypic heterogeneity, uncover the potential molecular etiologies of previously undiagnosed patients, and elucidate novel candidate cohesinopathy disease genes which potentially expand the genotype/phenotype characterizations of cohesinopathies.</p>
</sec>
<sec id="S6">
<title>MATERIALS AND METHODS</title>
<sec id="S7">
<title>Samples</title>
<p id="P10">The study has been conducted through a collaborative effort between Baylor Genetics (BG) and Baylor-Hopkins Center for Mendelian Genomics (BHCMG), and has been approved by the Institutional Review Board of Baylor College of Medicine. Approved consents of publishing photos have been obtained. Please see <xref ref-type="supplementary-material" rid="SD1">Supplemental Appendix</xref> for detailed descriptions of samples in BG and BHCMG. Selected patients with <italic>STAG1, STAG2</italic>, or <italic>PDS5A</italic> variants were enrolled after obtaining informed consent for further phenotypic characterization based on clinical notes submitted along with the CES order.</p>
</sec>
<sec id="S8">
<title>CES and variant interpretation</title>
<p id="P11">CES was performed as previously described<sup><xref ref-type="bibr" rid="R16">16</xref>,<xref ref-type="bibr" rid="R17">17</xref></sup>. The variant classification and interpretation were conducted by a clinical standard based on the American College of Medical Genetics and Genomics variant interpretation guidelines <sup><xref ref-type="bibr" rid="R18">18</xref></sup>. Details of the CES experimental procedures and sample-wise QC metrics can be found in <xref ref-type="supplementary-material" rid="SD3">Table S1</xref>. The possibility of mosaic variants in known CdLS genes<sup><xref ref-type="bibr" rid="R19">19</xref></sup> was carefully evaluated. A variant is considered mosaic only if the variant read versus total read ratio is below 30% and confirmatory Sanger sequencing demonstrates a comparable mosaic fraction.</p>
<p id="P12">The variants identified in this study have been submitted to ClinVar (accession numbers SCV000747051 - SCV000747093).</p>
</sec>
<sec id="S9">
<title>Chromosome microarray analysis (CMA)</title>
<p id="P13">The experimental design and data analysis of CMA were performed according to previously described procedures <sup><xref ref-type="bibr" rid="R20">20</xref></sup>.</p>
</sec>
<sec id="S10">
<title>X-chromosome inactivation (XCI) assay</title>
<p id="P14">XCI studies were performed for the patient samples with <italic>STAG2</italic> variants based on the protocol described by Allen <italic>et al</italic><sup><xref ref-type="bibr" rid="R21">21</xref></sup> with modifications. Please see <xref ref-type="supplementary-material" rid="SD1">Supplemental Appendix</xref> for detailed protocol.</p>
</sec>
<sec id="S11">
<title>Estimation of mutation prevalence in somatic cancer samples</title>
<p id="P15">The datasets from the COSMIC (<ext-link ext-link-type="uri" xlink:href="http://cancer.sanger.ac.uk/cosmic/download">http://cancer.sanger.ac.uk/cosmic/download</ext-link>) and ExAC (The Exome Aggregation Consortium, <ext-link ext-link-type="uri" xlink:href="http://exac.broadinstitute.org/">http://exac.broadinstitute.org/</ext-link>) <sup><xref ref-type="bibr" rid="R22">22</xref></sup> databases were used for the calculation. The normalized mutation abundance per gene in cancer samples is determined by the ratio between the mutation frequencies of COSMIC versus the ExAC (y-axis in <xref ref-type="fig" rid="F1">Figure 1C</xref>). Please see <xref ref-type="supplementary-material" rid="SD1">Supplemental Appendix</xref> for details.</p>
</sec>
</sec>
<sec id="S12">
<title>RESULTS</title>
<sec id="S13">
<title>Variants of established CdLS genes in the CES cohort</title>
<p id="P16">Based on a genotype-driven selection approach, we identified 33 patients with pathogenic or likely pathogenic variants in the well-recognized CdLS genes from the CES cohort. Those variants include heterozygous or hemizygous SNVs/indels in <italic>NIPBL</italic> (N=5), <italic>SMC1A</italic> (N=14, X-linked), <italic>SMC3</italic> (N=4), <italic>RAD21</italic> (N=2) and <italic>HDAC8</italic> (N=8, X-linked) (<xref ref-type="table" rid="T1">Table 1</xref>). Genic variant distribution was calculated to show the per gene contribution to molecular diagnosis among the five known CdLS genes (<xref ref-type="fig" rid="F1">Figure 1B</xref>). Of the 33 variants, 29 occurred <italic>de novo</italic> in the proband, three were inherited from a parent and one was of unknown inheritance (not maternally inherited, paternal sample not available, <xref ref-type="table" rid="T1">Table 1</xref>). Among the inherited variants, one variant in <italic>SMC1A</italic> was inherited from a symptomatic mother with a milder phenotype, demonstrating variable clinical presentation for X-linked dominant disorders; two variants in <italic>RAD21</italic> were inherited from symptomatic parents with milder phenotypes, documenting variable expressivity of defects in <italic>RAD21</italic>.</p>
<p id="P17">The CdLS patients in this cohort may be enriched for atypical or mild CdLS phenotypes, because those with classic CdLS presentation are more likely to be referred for specific single gene or panel testing instead of CES. We retrospectively examined the clinical notes submitted by the referral clinicians for their differential diagnoses prior to CES. CdLS was not included in the initial differential diagnoses for 60% of patients with a positive <italic>NIPBL</italic> finding, 93% with <italic>SMC1A</italic> and 75% with <italic>SMC3</italic> variants, and all those with <italic>RAD21</italic> or <italic>HDAC8</italic> variants (<xref ref-type="table" rid="T1">Table 1</xref>, <xref ref-type="fig" rid="F1">Figure 1B</xref>). These observations support the previous hypotheses that pathogenic variants in <italic>NIPBL</italic> have a better correlation with classic CdLS, while <italic>SMC1A</italic> and <italic>SMC3</italic> pathogenic variants may contribute to milder CdLS features; the phenotypes caused by pathogenic variants in <italic>RAD21</italic> and <italic>HDAC8</italic> become more variable and sometimes present atypical CdLS features<sup><xref ref-type="bibr" rid="R12">12</xref></sup>.</p>
<p id="P18">As a comparison to the genic distribution of our CES cohort, we analyzed the data from a phenotype-driven cohort of CdLS patients<sup><xref ref-type="bibr" rid="R19">19</xref></sup>. Moreover, we re-examined the genic variant distribution on an independent phenotype-driven CdLS cohort (N=41) from BHCMG, in which pathogenic or likely pathogenic variants in <italic>NIPBL</italic> (N=12), <italic>SMC1A</italic> (N=6), <italic>SMC3</italic> (N=2), and <italic>HDAC8</italic> (N=1) were identified (<xref ref-type="supplementary-material" rid="SD4">Table S2</xref>). The genic variant distribution of the BHCMG CdLS cohort is overall comparable with that calculated from the phenotype-driven cohort<sup><xref ref-type="bibr" rid="R19">19</xref></sup>. However, both of these largely deviated from our CES cohort (<xref ref-type="fig" rid="F1">Figure 1B</xref>). The proportion of patients with <italic>NIPBL</italic> pathogenic variants in our cohort was significantly lower in comparison to the aforementioned two phenotype-driven cohorts (Chi-squared test, both with <italic>p</italic> &lt; 0.001). The proportion of patients with <italic>SMC1A</italic> pathogenic variants in our cohort and the BHCMG were significantly higher than the other CdLS cohorts (Chi-squared test, both with <italic>p</italic> &lt; 0.02), indicating mild/atypical CdLS presentations in the BHCMG cohort. Therefore, the mutational spectrum in known CdLS genes in the CES cohort represent a distinct distortion and alternative perspective from phenotype-driven CdLS cohorts, where patients tend to present with classic phenotypes<sup><xref ref-type="bibr" rid="R11">11</xref></sup>.</p>
<p id="P19">Interestingly, 6/33 (18%) of the patients with positive findings from known CdLS genes carry a secondary diagnosis (<xref ref-type="table" rid="T1">Table 1</xref>), which is higher than the average observed fraction of patients with dual diagnoses from positive cases in the entire CES cohort (~5%)<sup><xref ref-type="bibr" rid="R23">23</xref></sup>. This is not unexpected because the predicted extent of multi-locus diagnosis can be as high as 14% under a Poisson distribution model<sup><xref ref-type="bibr" rid="R23">23</xref></sup>. The high representation of dual diagnosis and resultant blended phenotypes observed in this study may contribute to the complexity of the patients’ phenotypes, further obscuring the underlying molecular causes, making clinical diagnosis challenging without the assistance from objective molecular testing.</p>
</sec>
<sec id="S14">
<title>Candidate disease genes in the cohesin structural and regulatory components</title>
<p id="P20"><italic>STAG1, STAG2, PDS5A, PDS5B, WAPL</italic> and <italic>MAU2</italic> encode close interacting factors of NIPBL, SMC3, SMC1A, RAD21, and HDAC8 in the cohesin pathway, and thus may potentially supplement the locus heterogeneity of cohesinopathies. According to the ExAC database, <italic>NIPBL, SMC3, SMC1A</italic> and <italic>RAD21</italic> have Probability of LoF Intolerance (pLI) scores of 1.00, while <italic>HDAC8</italic> has a pLI of 0.92. Similarly, <italic>STAG1, STAG2, PDS5A, PDS5B, WAPL</italic> and <italic>MAU2</italic> all have pLI scores of 1.00, suggesting their intolerance to LoF variants (<xref ref-type="supplementary-material" rid="SD5">Table S3</xref>). In our CES cohort, we identified putative LoF (truncating/splicing) or <italic>de novo</italic> missense variants in <italic>STAG1</italic> (3), <italic>STAG2</italic> (2), <italic>PDS5A</italic> (2), and <italic>WAPL</italic> (1). Through collaboration with the Deciphering Developmental Disorder (DDD) study and BHCMG, three additional <italic>de novo</italic> variants in <italic>STAG2</italic> were identified.</p>
<p id="P21"><italic>De novo</italic> heterozygous SNVs/indels in <italic>STAG1</italic> (NM_005862.2), including one frameshift (c.2009_2012del [p.N670Ifs*25]) and one missense (c.1129C&gt;T [p.R377C]), were identified in Patients 1 and 2, respectively (<xref ref-type="fig" rid="F2">Figure 2A</xref>). Both patients had common clinical findings that included DD/ID, hypotonia, seizures, mild dysmorphic features and skeletal abnormalities (<xref ref-type="table" rid="T2">Table 2</xref>, <xref ref-type="supplementary-material" rid="SD6">Table S4</xref>). In addition, one heterozygous <italic>de novo</italic> missense SNV, c.253G&gt;A (p.V85I) in <italic>STAG1</italic>, was identified in Patient 3 (<xref ref-type="fig" rid="F2">Figure 2A</xref>) along with a heterozygous <italic>de novo</italic> c.1720-2A&gt;G SNV (observed twice in ExAC including one potentially being mosaic) in <italic>ASXL1</italic> (Bohring-Opitz syndrome; MIM# 605039). Patient 3 presented with global developmental delay, dysmorphic facial features, seizures, optic atrophy, mild hypotonia, skin hypopigmentation, hirsutism, possible autism spectrum disorder and structural brain abnormalities (<xref ref-type="table" rid="T2">Table 2</xref>, <xref ref-type="supplementary-material" rid="SD6">Table S4</xref>). The concurrent <italic>de novo</italic> variants in <italic>STAG1</italic> and <italic>ASXL1</italic> could possibly contribute to a dual molecular diagnosis of this patient.</p>
<p id="P22"><italic>De novo</italic> heterozygous/hemizygous SNVs/indels in <italic>STAG2</italic> (X-linked, NM_006603.4), including two stopgains, two missense and one frameshift, were identified in four females (Patient 7-10; Patient 7, c.418C&gt;T [p.Q140*]; Patient 8, c.1605T&gt;A [p.C535*]; Patient 9, c.1811G&gt;A [p.R604Q]; Patient 10, c.1658_1660delinsT[p.K553Ifs*6]) and one male (Patient 11 (hemizygous), c.476A&gt;G [p.Y159C]) (<xref ref-type="fig" rid="F2">Figure 2B</xref>).These patients shared common clinical findings of DD/ID, hypotonia, microcephaly, dysmorphic features and skeletal abnormalities (<xref ref-type="table" rid="T2">Table 2</xref>, <xref ref-type="supplementary-material" rid="SD6">Table S4</xref>). Skewed X-inactivation (XCI) was observed in Patient 8, whereas XCI was non-informative for Patient 7 due to homozygosity of the marker being used for the XCI study (data not shown). In our study, truncating variants were identified in 3/4 female patients, but not in males. Although this observation is based on a limited number of patients, it is consistent with the hypothesis that truncating variants of X-linked genes may impose more severe pathogenic effect on males than females.</p>
<p id="P23">One heterozygous SNV, c.2275G&gt;T (p.E759*), in <italic>PDS5A</italic> (NM_001100399.1) was identified in Patient 13 with severe developmental delay, marked hypotonia, failure to thrive, dysmorphic features, hyperextensible knees, eye anomalies and skeletal abnormalities (<xref ref-type="table" rid="T2">Table 2</xref>, <xref ref-type="supplementary-material" rid="SD6">Table S4</xref>). Interestingly, this patient also had a concurrent heterozygous <italic>de novo</italic> SNV, c.3325A&gt;T (p.K1109*), in <italic>ASXL3</italic> (Bainbridge-Ropers syndrome, MIM# 615485), which presumably explains the major phenotypes. This <italic>PDS5A</italic> variant is predicted to introduce a premature stop codon in <italic>PDS5A</italic> in the longer transcript (NM_001100399.1) but does not affect the shorter transcript (NM_001100400.1), suggesting a potential mild defect caused by this variant. However, the role of different isoforms of PDS5A in the cohesin complex is not well-established in the literature. Notably, the father of Patient 12, who shared the <italic>PDS5A</italic> p.E759* variant, had speech impediment. Although the pathogenicity of the p.E759* variant in <italic>PDS5A</italic> remains to be investigated, it may modulate the patient’s phenotype and constitute a dual diagnosis together with <italic>ASXL3</italic>. In addition, one heterozygous <italic>de novo</italic> SNV (c.654+5G&gt;C) in <italic>PDS5A</italic> was identified in another patient with neurodevelopmental disorders. This intronic <italic>PDS5A</italic> variant was predicted to affect splicing of the major mRNA transcript of <italic>PDS5A</italic> by prediction programs including SpliceSiteFinder-like and MaxEntScan (<ext-link ext-link-type="uri" xlink:href="http://www.interactive-biosoftware.com/doc/alamut-visual/2.6/splicing.html">http://www.interactive-biosoftware.com/doc/alamut-visual/2.6/splicing.html</ext-link>).</p>
<p id="P24">Finally, one <italic>de novo</italic> heterozygous SNV in <italic>WAPL</italic> (NM_015045.3), c.2192G&gt;A (p.R731H) was identified in one patient with neurodevelopmental disorders. This observation corroborates a previous report in which a partial duplication involving <italic>WAPL</italic> was identified in a patient from a phenotype-driven CdLS cohort<sup><xref ref-type="bibr" rid="R24">24</xref></sup>, providing further evidence for <italic>WAPL</italic> as a candidate disease gene.</p>
<p id="P25">Each of the variants in <italic>STAG1, STAG2, PDS5A</italic> and <italic>WAPL</italic> described above were not observed in the control population databases including ExAC and ESP5400 (NHLBI Exome Sequencing Project, <ext-link ext-link-type="uri" xlink:href="http://evs.gs.washington.edu/EVS/">http://evs.gs.washington.edu/EVS/</ext-link>). The interpretation of deleterious effects of the <italic>de novo</italic> missense SNVs identified in this study was supported by multiple prediction algorithms (<xref ref-type="supplementary-material" rid="SD7">Table S5</xref>).</p>
<p id="P26">We identified CNV deletions affecting <italic>STAG1</italic> and <italic>STAG2</italic> in our clinical CMA cohort, supporting LoF as the presumed disease-contributing mechanism; no putative LoF CNVs of <italic>PDS5A, PDS5B, WAPL</italic> or <italic>MAU2</italic> were identified. In total, we identified three CNV deletions affecting <italic>STAG1</italic> (two <italic>de novo</italic>, one of unknown inheritance) in patients with developmental disorders (<xref ref-type="fig" rid="F2">Figure 2C</xref>, <xref ref-type="supplementary-material" rid="SD8">Table S6</xref>). In the literature, six CNV deletions overlapping <italic>STAG1</italic> were reported, with the smallest two deletions being intragenic (exons 2-5 and exons 13-18, respectively)<sup><xref ref-type="bibr" rid="R13">13</xref></sup>. Moreover, eight cases with neurodevelopmental disorders were reported in the DECIPHER database harboring relatively small-sized deletions (&lt; 5 Mb) affecting <italic>STAG1</italic> (<ext-link ext-link-type="uri" xlink:href="https://decipher.sanger.ac.uk/">https://decipher.sanger.ac.uk/</ext-link>)<sup><xref ref-type="bibr" rid="R25">25</xref></sup> (<xref ref-type="fig" rid="F2">Figure 2C</xref>, <xref ref-type="supplementary-material" rid="SD8">Table S6</xref>). These <italic>STAG1</italic>-overlapping deletions identified in affected patients strongly indicate that haploinsufficiency is likely to be the disease-contributing mechanism for <italic>STAG1</italic>. In addition, a 33.9 Kb CNV deletion with unknown inheritance encompassing exons 15-32 of <italic>STAG2</italic> (predicted to result in an in-frame deletion p.L473_L1198del), was identified in Patient 12 with dysmorphic features, microcephaly and seizures (<xref ref-type="fig" rid="F2">Figure 2B</xref>, <xref ref-type="supplementary-material" rid="SD8">Table S6</xref>). This female patient showed skewed XCI, consistent with the observation in Patient 8.</p>
</sec>
<sec id="S15">
<title>Patients with <italic>STAG1</italic> and <italic>STAG2</italic> variants have phenotypes overlapping the CdLS-spectrum</title>
<p id="P27">We evaluated the clinical phenotypes for Patient 1-2 (<italic>STAG1</italic>) and Patient 7-11 (<italic>STAG2</italic>). Patient 3 (<italic>STAG1</italic>) was excluded from the evaluation since the identification of concurrent <italic>de novo</italic> variants in <italic>ASXL1</italic> together with <italic>STAG1</italic> may largely complicate the <italic>STAG1</italic>-alone phenotypes.</p>
<p id="P28">Patients described in this paper presented for genetic evaluation due to developmental delay and/or congenital anomalies but not with classic distinctive facial features or a recognizable pattern of malformation suggestive for a particular syndrome such as CdLS (<xref ref-type="fig" rid="F2">Figure 2D</xref>). The most common features among these patients with <italic>STAG1</italic> and <italic>STAG2</italic> variants were DD/ID, behavioral problems, hypotonia, seizures, microcephaly, failure to thrive, short stature, mild dysmorphic features, and 2-3 toe syndactyly (<xref ref-type="table" rid="T2">Table 2</xref>).</p>
<p id="P29">Clinical profiling suggested many overlapping features with CdLS, which include DD/ID, growth failure including short stature and microcephaly, hearing loss, synophrys, micrognathia, limb anomalies and hypoplastic male genitalia. Some other less common features of CdLS, such as cutis marmorata, myopia, congenital diaphragmatic hernia (CDH), and renal anomalies among others, were also observed in several of these patients. A more detailed characterization is described in <xref ref-type="table" rid="T2">Table 2</xref> and <xref ref-type="supplementary-material" rid="SD6">Table S4</xref>.</p>
<p id="P30">Among the distinctive craniofacial features present in over 95% of the patients with a clinical diagnosis of CdLS<sup><xref ref-type="bibr" rid="R11">11</xref></sup>, our patients collectively had microbrachycephaly, low set ears, synophrys, long curly eyelashes, broad nasal bridge, anteverted nares, long and smooth philtrum, thin upper lip and micrognathia; however, these features were not present concurrently in a single patient. Interestingly while microcephaly is one of the most characteristic features in CdLS, only 4/7 patients (one <italic>STAG1</italic> and three <italic>STAG2</italic>) had microcephaly. Although the numbers are small, a higher percentage of microcephaly was observed in patients with a <italic>STAG2</italic> variant (3/5) in comparison to <italic>STAG1</italic> (1/2). In contrast to CdLS, where mild to severe limb anomalies are common and are usually helpful to establish a clinical diagnosis, the patients in this study had common but more subtle findings in their extremities, such as fifth finger clinodactyly and syndactyly. Skeletal anomalies including scoliosis (3/7), vertebral anomalies (3/7) and rib fusion (2/7) were observed in our patients, all with variants in <italic>STAG2</italic>. Even though these skeletal anomalies can be observed in patients with classic CdLS, vertebral and rib anomalies would be considered as rare or atypical features for CdLS.</p>
<p id="P31">Comparing patients with <italic>STAG1</italic> or <italic>STAG2</italic> variants, DD/ID and mild dysmorphic features have been consistently observed, which is in line with the previous reports<sup><xref ref-type="bibr" rid="R13">13</xref>–<xref ref-type="bibr" rid="R15">15</xref></sup> (<xref ref-type="table" rid="T2">Table 2</xref>). Despite the small cohort size, it seems that patients with <italic>STAG2</italic> variants have more multisystem congenital anomalies such as CDH, congenital heart disease and vertebral anomalies. Growth failure was observed as well, but apparently more in the postnatal period than prenatally. Patients with a <italic>STAG2</italic> variant appear to have more severe growth failure especially in weight and length parameters compared to those with <italic>STAG1</italic> variants.</p>
<p id="P32">Although <italic>STAG1</italic> and <italic>STAG2</italic> have been implicated in cancers due to their function in the cohesin pathway and the observation of chromosomal segregation defects in defective cell lines (e.g. <italic>STAG2</italic> as an indicator for myeloid neoplasms), onset of tumors has not been observed in our study nor in the patients reported in the literature with developmental disorders caused by constitutional pathogenic variants in <italic>STAG1</italic> and <italic>STAG2</italic><sup><xref ref-type="bibr" rid="R13">13</xref>–<xref ref-type="bibr" rid="R15">15</xref></sup>. Moreover, no obvious increased risk of cancer is reported in patients with other cohesinopathies caused by defects in genes such as <italic>NIPBL, SMC1A</italic>, and <italic>SMC3</italic><sup><xref ref-type="bibr" rid="R1">1</xref></sup>. Consistent with this observation, our chromosome analysis of one patient (Patient 7) did not reveal any evidence for chromosomal segregation defects (data not shown).</p>
</sec>
</sec>
<sec id="S16">
<title>DISCUSSION</title>
<p id="P33">In this study, we applied a genotype-driven approach to decipher the genetic causes of cohesinopathy from a CES perspective. We describe a series of disease-contributing variants in known cohesinopathy genes, and also provide molecular evidence supporting the candidacy of recently described or new disease genes.</p>
<p id="P34"><italic>NIPBL</italic> defects are underrepresented in this cohort likely due to ascertainment bias associated with its more clinically recognizable presentations. The scarcity of putative LoF variants for certain cohesin genes including <italic>PDS5B</italic> and <italic>MAU2</italic> in this cohort indicates that LoF variants in these genes may exert strong pathogenic effects on early development leading to incompatibility with life. Alternatively, the lack of evidence supporting the pathogenicity of variants in <italic>PDS5B</italic> and <italic>MAU2</italic> could reflect limitations of interpreting missense variants based on proband-only CES. <italic>HDAC8</italic> and <italic>SMC1A</italic> are the only two well-studied X-linked genes among the cohesin components. They seem to be relatively spared from the strong selection in human development possibly due to protection of pathogenic alleles in the gene pool by XCI in females. Consistently, variants in these two genes are highly represented in the CES cohort as compared to cohorts assembled by phenotypic characterization (<xref ref-type="fig" rid="F1">Figure 1B</xref>).</p>
<p id="P35">Patients harboring <italic>STAG1</italic> or <italic>STAG2</italic> variants seem to share many of the clinical features seen in the well-described CdLS phenotype. Apparently affected patients in our cohort are developmentally and intellectually as impaired as those with CdLS. However, their spectrum of growth, craniofacial and musculoskeletal features are not as severe as the spectrum of CdLS. Overall, only one patient (Patient 3 [<italic>STAG1</italic>]) fulfills the diagnostic criteria for CdLS by meeting the CdLS characteristic facial features <sup><xref ref-type="bibr" rid="R26">26</xref></sup>. Note that the concurrent <italic>de novo</italic> variant in <italic>ASXL1</italic> may largely contribute to the differential diagnosis of CdLS for Patient 3 (<xref ref-type="supplementary-material" rid="SD9">Table S7</xref>). Although the currently available clinical information we had might not be as sufficient for a diagnosis of CdLS or other cohesinopathies, a “CdLS-like” syndrome started to emerge. The <italic>STAG1</italic>/<italic>STAG2</italic>-related disorders seem to be at the mild end of the CdLS spectrum, making the clinical diagnosis for these two genes more challenging for physicians. Putting together the constellation of clinical features might help to end the diagnostic odyssey earlier, and with this series of cases awareness can be extended. Given the challenges, comprehensive genomic analysis, such as CES, should be offered to efficiently provide a molecular diagnosis for these cohesinopathy conditions.</p>
<p id="P36">Notably, the LoF <italic>PDS5A</italic> variant (Patient 13) was inherited from a father with speech impediment. Although the phenotypic consequence of this variant remains unclear (as discussed in the RESULTS), its potential contribution cannot be completely ruled out. Unfortunately, samples from the parental grandparents or other relatives are not available for testing. Defects in the cohesin complex, as demonstrated in the CdLS genes, are likely to be detrimental to proper organismal development, milder phenotypic consequences have been observed<sup><xref ref-type="bibr" rid="R11">11</xref></sup>. With our experience of known CdLS gene variants among 10,698 individuals, two distinct novel pathogenic variants in <italic>RAD21</italic> as well as one novel pathogenic variant in <italic>SMC1A</italic> (X-linked) were identified in three unrelated patients with neurodevelopmental disorders, all inherited from affected parents with milder phenotypes (<xref ref-type="table" rid="T1">Table 1</xref>). Moreover, transmission of pathogenic variant between generations has been reported in <italic>STAG1</italic><sup><xref ref-type="bibr" rid="R13">13</xref></sup>. Therefore, with the reported variable expressivity of the cohesin defects, it is plausible that the reproductive potential, genetic transmission and severity of phenotype may be dependent on various factors, including the components being affected, the mutation types, the inheritance mode (e.g. X-linked or autosomal dominant) and the downstream pathways disrupted by defects in a particular component. Thus, additional genotype-phenotype correlation studies are warranted to further delineate the spectrum of cohesinopathies.</p>
<p id="P37">The mutational landscape of cohesin genes in somatic cancer may represent an alternative view to reflect contribution of these genes to biological processes, with minimum selection as compared to that imposed during early human development. Among cancer samples deposited to the COSMIC database subjected to genome wide screening, truncating variants were observed in all cohesin genes. While missense variants did not show any substantive difference between cohesin genes, putative LoF variants in <italic>STAG2</italic> were highly represented in the somatic cancer cohort (<xref ref-type="fig" rid="F1">Figure 1C</xref>). LoF variants in <italic>STAG2</italic> have been significantly associated with several cancers<sup><xref ref-type="bibr" rid="R27">27</xref>,<xref ref-type="bibr" rid="R28">28</xref></sup>, suggesting a likely pleiotropic effect of <italic>STAG2</italic>, possibly with strong involvement in tumorigenesis. Interestingly, we have observed a patient with mosaic <italic>STAG2</italic> LoF variant in the CES cohort. The patient does not have neurodevelopmental problems, but instead presented with hematological malignancy. Therefore, we considered the <italic>STAG2</italic> defect in this patient as not being causal for a cohesinopathy. Consequently, caution should be taken when interpreting variants in cohesin genes by considering the possibility that they may arise as somatic changes after the critical period of early human development.</p>
<p id="P38">Accumulating evidence suggest that cohesin contributes to the topological organization of the genome, regulates DNA replication, and facilitates long-range gene transcription regulation<sup><xref ref-type="bibr" rid="R2">2</xref>,<xref ref-type="bibr" rid="R29">29</xref>,<xref ref-type="bibr" rid="R30">30</xref></sup>. In addition, the interactions between cohesin and other transcription machinery and chromatin remodeling complexes to recognize specific genomic loci and regulate gene transcription have aggregated these complexes into the same pathways of transcription regulation<sup><xref ref-type="bibr" rid="R30">30</xref>–<xref ref-type="bibr" rid="R33">33</xref></sup>. Notably, genes encoding components of chromosome remodeling and transcription regulation machineries, such as <italic>ANKRD11, AFF4, KMT2A, TAF1</italic> and <italic>TAF6</italic>, have been associated with phenotypes reminiscent of CdLS<sup><xref ref-type="bibr" rid="R3">3</xref>,<xref ref-type="bibr" rid="R19">19</xref>,<xref ref-type="bibr" rid="R34">34</xref>–<xref ref-type="bibr" rid="R36">36</xref></sup>. Such findings expand the molecular mechanism underlying cohesinopathies into transcriptional regulation. Interestingly, gene expression studies of patients with elevated dosage of <italic>STAG2</italic> reveal a dysregulated transcriptome and pinpoints altered expression levels of developmentally important genes<sup><xref ref-type="bibr" rid="R37">37</xref></sup>. Therefore, the versatility of cohesin in cohesion and transcription regulation warrants a further investigation of its downstream effectors.</p>
<p id="P39">In summary, the genotype-first approach focusing on a specific pathway enabled us to investigate patients with non-classic cohesinopathy phenotypes; this approach also allowed us to discover patients with variants in new or recently reported disease genes, namely <italic>STAG1, STAG2</italic>, and potentially <italic>PDS5A</italic> and <italic>WAPL</italic>, which may further expand the genetic heterogeneity underlying cohesinopathies. Future studies of cellular phenotypes, with regard to functional studies of DNA repair and transcriptome analysis, are warranted to further elucidate the mechanistic consequences due to defects in specific cohesin components, which may shed light on precision medicine efforts targeting distinct molecular pathways.</p>
</sec>
<sec id="SM1" sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="SD1">
<label>Supplementary Appendix</label>
<media id="d36e1746" orientation="portrait" position="anchor" xlink:href="NIHMS973104-supplement-Supplementary_Appendix.docx" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD2">
<label>Supplementary legend</label>
<media id="d36e1750" orientation="portrait" position="anchor" xlink:href="NIHMS973104-supplement-Supplementary_legend.docx" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD3">
<label>Table S1</label>
<media id="d36e1754" orientation="portrait" position="anchor" xlink:href="NIHMS973104-supplement-Table_S1.docx" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD4">
<label>Table S2</label>
<media id="d36e1758" orientation="portrait" position="anchor" xlink:href="NIHMS973104-supplement-Table_S2.xlsx" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD5">
<label>Table S3</label>
<media id="d36e1762" orientation="portrait" position="anchor" xlink:href="NIHMS973104-supplement-Table_S3.xlsx" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD6">
<label>Table S4</label>
<media id="d36e1766" orientation="portrait" position="anchor" xlink:href="NIHMS973104-supplement-Table_S4.xlsx" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD7">
<label>Table S5</label>
<media id="d36e1770" orientation="portrait" position="anchor" xlink:href="NIHMS973104-supplement-Table_S5.docx" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD8">
<label>Table S6</label>
<media id="d36e1774" orientation="portrait" position="anchor" xlink:href="NIHMS973104-supplement-Table_S6.xlsx" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD9">
<label>Table S7</label>
<media id="d36e1778" orientation="portrait" position="anchor" xlink:href="NIHMS973104-supplement-Table_S7.xlsx" xlink:type="simple"></media>
</supplementary-material>
</sec>
</body>
<back>
<ack id="S17">
<title>Acknowledgement</title>
<p id="P40">This study was supported in part by the National Human Genome Research Institute/National Heart Lung and Blood Institute (NHGRI/NHLBI) grant UM1HG006542 to the BHCMG; and National Institutes of Neurological Disorders and Stroke (NINDS) grant R35 NS105078-01 to JRL. JEP was supported by the NHGRI grant K08 HG008986. We acknowledge Dr. Sureni V. Mullegama for critical comments on this manuscript.</p>
</ack>
<fn-group>
<fn id="FN1">
<p id="P41">Disclosure statements</p>
<p id="P42">Baylor College of Medicine (BCM) and Miraca Holdings Inc. have formed a joint venture with shared ownership and governance of Baylor Genetics (BG), formerly the Baylor Miraca Genetics Laboratories (BMGL), which performs chromosomal microarray analysis and clinical exome sequencing. JR, VP, WJ, CS, WB, SWC, AMB, JLS, CE, YY, RX and PL are employees of BCM and derive support through a professional services agreement with the BG. JRL serves on the Scientific Advisory Board of the BG. JRL has stock ownership in 23andMe, is a paid consultant for Regeneron Pharmaceuticals, has stock options in Lasergen, Inc and is a co-inventor on multiple United States and European patents related to molecular diagnostics for inherited neuropathies, eye diseases and bacterial genomic fingerprinting. Other authors have no disclosures relevant to the manuscript. All authors read and approved the final manuscript.</p>
<p id="P43">This study makes use of data generated by the DECIPHER community. A full list of centres who contributed to the generation of the data is available from <ext-link ext-link-type="uri" xlink:href="http://decipher.sanger.ac.uk">http://decipher.sanger.ac.uk</ext-link> and via email from <email>decipher@sanger.ac.uk</email>. Funding for the project was provided by the Wellcome Trust.</p>
<p id="P44">The DDD study presents independent research commissioned by the Health Innovation Challenge Fund [grant number HICF-1009-003], a parallel funding partnership between the Wellcome Trust and the Department of Health, and the Wellcome Trust Sanger Institute [grant number WT098051]. The views expressed in this publication are those of the author(s) and not necessarily those of the Wellcome Trust or the Department of Health. The study has UK Research Ethics Committee approval (10/H0305/83, granted by the Cambridge South REC, and GEN/284/12 granted by the Republic of Ireland REC). The research team acknowledges the support of the National Institute for Health Research, through the Comprehensive Clinical Research Network.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="R1">
<label>1.</label>
<mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>J</given-names></name>, <name><surname>Krantz</surname><given-names>ID</given-names></name>. <article-title>Cornelia de Lange syndrome, cohesin, and beyond</article-title>. <source/>Clin. Genet
<month>10</month>
<year>2009</year>;<volume>76</volume>(<issue>4</issue>):<fpage>303</fpage>–<lpage>314</lpage>.<pub-id pub-id-type="pmid">19793304</pub-id></mixed-citation>
</ref>
<ref id="R2">
<label>2.</label>
<mixed-citation publication-type="journal"><name><surname>Losada</surname><given-names>A</given-names></name>
<article-title>Cohesin in cancer: chromosome segregation and beyond</article-title>. <source/>Nat. Rev. Cancer. <month>6</month>
<year>2014</year>;<volume>14</volume>(<issue>6</issue>):<fpage>389</fpage>–<lpage>393</lpage>.<pub-id pub-id-type="pmid">24854081</pub-id></mixed-citation>
</ref>
<ref id="R3">
<label>3.</label>
<mixed-citation publication-type="journal"><name><surname>Yuan</surname><given-names>B</given-names></name>, <name><surname>Pehlivan</surname><given-names>D</given-names></name>, <name><surname>Karaca</surname><given-names>E</given-names></name>, <etal></etal>
<article-title>Global transcriptional disturbances underlie Cornelia de Lange syndrome and related phenotypes</article-title>. <source/>J. Clin. Invest
<month>2</month>
<year>2015</year>;<volume>125</volume>(<issue>2</issue>):<fpage>636</fpage>–<lpage>651</lpage>.<pub-id pub-id-type="pmid">25574841</pub-id></mixed-citation>
</ref>
<ref id="R4">
<label>4.</label>
<mixed-citation publication-type="journal"><name><surname>Krantz</surname><given-names>ID</given-names></name>, <name><surname>McCallum</surname><given-names>J</given-names></name>, <name><surname>DeScipio</surname><given-names>C</given-names></name>, <etal></etal>
<article-title>Cornelia de Lange syndrome is caused by mutations in NIPBL, the human homolog of Drosophila melanogaster Nipped-B</article-title>. <source/>Nat. Genet
<month>6</month>
<year>2004</year>;<volume>36</volume>(<issue>6</issue>):<fpage>631</fpage>–<lpage>635</lpage>.<pub-id pub-id-type="pmid">15146186</pub-id></mixed-citation>
</ref>
<ref id="R5">
<label>5.</label>
<mixed-citation publication-type="journal"><name><surname>Pehlivan</surname><given-names>D</given-names></name>, <name><surname>Hullings</surname><given-names>M</given-names></name>, <name><surname>Carvalho</surname><given-names>CM</given-names></name>, <etal></etal>
<article-title>NIPBL rearrangements in Cornelia de Lange syndrome: evidence for replicative mechanism and genotype-phenotype correlation</article-title>. <source/>Genet. Med
<month>3</month>
<year>2012</year>;<volume>14</volume>(<issue>3</issue>):<fpage>313</fpage>–<lpage>322</lpage>.<pub-id pub-id-type="pmid">22241092</pub-id></mixed-citation>
</ref>
<ref id="R6">
<label>6.</label>
<mixed-citation publication-type="journal"><name><surname>Tonkin</surname><given-names>ET</given-names></name>, <name><surname>Wang</surname><given-names>TJ</given-names></name>, <name><surname>Lisgo</surname><given-names>S</given-names></name>, <name><surname>Bamshad</surname><given-names>MJ</given-names></name>, <name><surname>Strachan</surname><given-names>T</given-names></name>. <article-title>NIPBL, encoding a homolog of fungal Scc2-type sister chromatid cohesion proteins and fly Nipped-B, is mutated in Cornelia de Lange syndrome</article-title>. <source/>Nat. Genet
<month>6</month>
<year>2004</year>;<volume>36</volume>(<issue>6</issue>):<fpage>636</fpage>–<lpage>641</lpage>.<pub-id pub-id-type="pmid">15146185</pub-id></mixed-citation>
</ref>
<ref id="R7">
<label>7.</label>
<mixed-citation publication-type="journal"><name><surname>Deardorff</surname><given-names>MA</given-names></name>, <name><surname>Bando</surname><given-names>M</given-names></name>, <name><surname>Nakato</surname><given-names>R</given-names></name>, <etal></etal>
<article-title>HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle</article-title>. <source/>Nature. <month>9</month>
<day>13</day>
<year>2012</year>;<volume>489</volume>(<issue>7415</issue>):<fpage>313</fpage>–<lpage>317</lpage>.<pub-id pub-id-type="pmid">22885700</pub-id></mixed-citation>
</ref>
<ref id="R8">
<label>8.</label>
<mixed-citation publication-type="journal"><name><surname>Deardorff</surname><given-names>MA</given-names></name>, <name><surname>Kaur</surname><given-names>M</given-names></name>, <name><surname>Yaeger</surname><given-names>D</given-names></name>, <etal></etal>
<article-title>Mutations in cohesin complex members SMC3 and SMC1A cause a mild variant of cornelia de Lange syndrome with predominant mental retardation</article-title>. <source/>Am. J. Hum. Genet
<month>3</month>
<year>2007</year>;<volume>80</volume>(<issue>3</issue>):<fpage>485</fpage>–<lpage>494</lpage>.<pub-id pub-id-type="pmid">17273969</pub-id></mixed-citation>
</ref>
<ref id="R9">
<label>9.</label>
<mixed-citation publication-type="journal"><name><surname>Deardorff</surname><given-names>MA</given-names></name>, <name><surname>Wilde</surname><given-names>JJ</given-names></name>, <name><surname>Albrecht</surname><given-names>M</given-names></name>, <etal></etal>
<article-title>RAD21 mutations cause a human cohesinopathy</article-title>. <source/>Am. J. Hum. Genet
<month>6</month>
<day>8</day>
<year>2012</year>;<volume>90</volume>(<issue>6</issue>):<fpage>1014</fpage>–<lpage>1027</lpage>.<pub-id pub-id-type="pmid">22633399</pub-id></mixed-citation>
</ref>
<ref id="R10">
<label>10.</label>
<mixed-citation publication-type="journal"><name><surname>Musio</surname><given-names>A</given-names></name>, <name><surname>Selicorni</surname><given-names>A</given-names></name>, <name><surname>Focarelli</surname><given-names>ML</given-names></name>, <etal></etal>
<article-title>X-linked Cornelia de Lange syndrome owing to SMC1L1 mutations</article-title>. <source/>Nat. Genet
<month>5</month>
<year>2006</year>;<volume>38</volume>(<issue>5</issue>):<fpage>528</fpage>–<lpage>530</lpage>.<pub-id pub-id-type="pmid">16604071</pub-id></mixed-citation>
</ref>
<ref id="R11">
<label>11.</label>
<mixed-citation publication-type="book"><name><surname>Deardorff</surname><given-names>MA</given-names></name>, <name><surname>Noon</surname><given-names>SE</given-names></name>, <name><surname>Krantz</surname><given-names>ID</given-names></name>. <chapter-title>Cornelia de Lange Syndrome</chapter-title>
<source/>GeneReviews® [Internet]. <publisher-loc>Seattle (WA)</publisher-loc>: <publisher-name>University of Washington, Seattle</publisher-name>; <fpage>1993</fpage>–<lpage>2017</lpage>. <year>2005</year>.</mixed-citation>
</ref>
<ref id="R12">
<label>12.</label>
<mixed-citation publication-type="journal"><name><surname>Mannini</surname><given-names>L</given-names></name>, <name><surname>Cucco</surname><given-names>F</given-names></name>, <name><surname>Quarantotti</surname><given-names>V</given-names></name>, <name><surname>Krantz</surname><given-names>ID</given-names></name>, <name><surname>Musio</surname><given-names>A</given-names></name>. <article-title>Mutation spectrum and genotype-phenotype correlation in Cornelia de Lange syndrome</article-title>. <source/>Hum. Mutat
<month>12</month>
<year>2013</year>;<volume>34</volume>(<issue>12</issue>):<fpage>1589</fpage>–<lpage>1596</lpage>.<pub-id pub-id-type="pmid">24038889</pub-id></mixed-citation>
</ref>
<ref id="R13">
<label>13.</label>
<mixed-citation publication-type="journal"><name><surname>Lehalle</surname><given-names>D</given-names></name>, <name><surname>Mosca-Boidron</surname><given-names>AL</given-names></name>, <name><surname>Begtrup</surname><given-names>A</given-names></name>, <etal></etal>
<article-title>STAG1 mutations cause a novel cohesinopathy characterised by unspecific syndromic intellectual disability</article-title>. <source/>J. Med. Genet
<month>1</month>
<day>24</day>
<year>2017</year>.</mixed-citation>
</ref>
<ref id="R14">
<label>14.</label>
<mixed-citation publication-type="journal"><name><surname>Mullegama</surname><given-names>SV</given-names></name>, <name><surname>Klein</surname><given-names>SD</given-names></name>, <name><surname>Mulatinho</surname><given-names>MV</given-names></name>, <etal></etal>
<article-title>De novo loss-of-function variants in STAG2 are associated with developmental delay, microcephaly, and congenital anomalies</article-title>. <source/>Am. J. Med. Genet. A. <month>5</month>
<year>2017</year>;<volume>173</volume>(<issue>5</issue>):<fpage>1319</fpage>–<lpage>1327</lpage>.<pub-id pub-id-type="pmid">28296084</pub-id></mixed-citation>
</ref>
<ref id="R15">
<label>15.</label>
<mixed-citation publication-type="journal"><name><surname>Soardi</surname><given-names>FC</given-names></name>, <name><surname>Machado-Silva</surname><given-names>A</given-names></name>, <name><surname>Linhares</surname><given-names>ND</given-names></name>, <etal></etal>
<article-title>Familial STAG2 germline mutation defines a new human cohesinopathy</article-title>. <source/>NPJ genomic medicine. <year>2017</year>;<volume>2</volume>:<fpage>7</fpage>.<pub-id pub-id-type="pmid">29263825</pub-id></mixed-citation>
</ref>
<ref id="R16">
<label>16.</label>
<mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>Y</given-names></name>, <name><surname>Muzny</surname><given-names>DM</given-names></name>, <name><surname>Reid</surname><given-names>JG</given-names></name>, <etal></etal>
<article-title>Clinical whole-exome sequencing for the diagnosis of mendelian disorders</article-title>. <source/>N. Engl. J. Med
<month>10</month>
<day>17</day>
<year>2013</year>;<volume>369</volume>(<issue>16</issue>):<fpage>1502</fpage>–<lpage>1511</lpage>.<pub-id pub-id-type="pmid">24088041</pub-id></mixed-citation>
</ref>
<ref id="R17">
<label>17.</label>
<mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>Y</given-names></name>, <name><surname>Muzny</surname><given-names>DM</given-names></name>, <name><surname>Xia</surname><given-names>F</given-names></name>, <etal></etal>
<article-title>Molecular findings among patients referred for clinical whole-exome sequencing</article-title>. <source/>JAMA. <month>11</month>
<day>12</day>
<year>2014</year>;<volume>312</volume>(<issue>18</issue>):<fpage>1870</fpage>–<lpage>1879</lpage>.<pub-id pub-id-type="pmid">25326635</pub-id></mixed-citation>
</ref>
<ref id="R18">
<label>18.</label>
<mixed-citation publication-type="journal"><name><surname>Richards</surname><given-names>S</given-names></name>, <name><surname>Aziz</surname><given-names>N</given-names></name>, <name><surname>Bale</surname><given-names>S</given-names></name>, <etal></etal>
<article-title>Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology</article-title>. <source/>Genet. Med
<month>5</month>
<year>2015</year>;<volume>17</volume>(<issue>5</issue>):<fpage>405</fpage>–<lpage>424</lpage>.<pub-id pub-id-type="pmid">25741868</pub-id></mixed-citation>
</ref>
<ref id="R19">
<label>19.</label>
<mixed-citation publication-type="journal"><name><surname>Ansari</surname><given-names>M</given-names></name>, <name><surname>Poke</surname><given-names>G</given-names></name>, <name><surname>Ferry</surname><given-names>Q</given-names></name>, <etal></etal>
<article-title>Genetic heterogeneity in Cornelia de Lange syndrome (CdLS) and CdLS-like phenotypes with observed and predicted levels of mosaicism</article-title>. <source/>J. Med. Genet
<month>10</month>
<year>2014</year>;<volume>51</volume>(<issue>10</issue>):<fpage>659</fpage>–<lpage>668</lpage>.<pub-id pub-id-type="pmid">25125236</pub-id></mixed-citation>
</ref>
<ref id="R20">
<label>20.</label>
<mixed-citation publication-type="journal"><name><surname>Gambin</surname><given-names>T</given-names></name>, <name><surname>Yuan</surname><given-names>B</given-names></name>, <name><surname>Bi</surname><given-names>W</given-names></name>, <etal></etal>
<article-title>Identification of novel candidate disease genes from de novo exonic copy number variants</article-title>. <source/>Genome Med
<month>9</month>
<day>21</day>
<year>2017</year>;<volume>9</volume>(<issue>1</issue>):<fpage>83</fpage>.<pub-id pub-id-type="pmid">28934986</pub-id></mixed-citation>
</ref>
<ref id="R21">
<label>21.</label>
<mixed-citation publication-type="journal"><name><surname>Allen</surname><given-names>RC</given-names></name>, <name><surname>Zoghbi</surname><given-names>HY</given-names></name>, <name><surname>Moseley</surname><given-names>AB</given-names></name>, <name><surname>Rosenblatt</surname><given-names>HM</given-names></name>, <name><surname>Belmont</surname><given-names>JW</given-names></name>. <article-title>Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation</article-title>. <source/>Am. J. Hum. Genet
<month>12</month>
<year>1992</year>;<volume>51</volume>(<issue>6</issue>):<fpage>1229</fpage>–<lpage>1239</lpage>.<pub-id pub-id-type="pmid">1281384</pub-id></mixed-citation>
</ref>
<ref id="R22">
<label>22.</label>
<mixed-citation publication-type="journal"><name><surname>Lek</surname><given-names>M</given-names></name>, <name><surname>Karczewski</surname><given-names>KJ</given-names></name>, <name><surname>Minikel</surname><given-names>EV</given-names></name>, <etal></etal>
<article-title>Analysis of protein-coding genetic variation in 60,706 humans</article-title>. <source/>Nature. <month>8</month>
<day>18</day>
<year>2016</year>;<volume>536</volume>(<issue>7616</issue>):<fpage>285</fpage>–<lpage>291</lpage>.<pub-id pub-id-type="pmid">27535533</pub-id></mixed-citation>
</ref>
<ref id="R23">
<label>23.</label>
<mixed-citation publication-type="journal"><name><surname>Posey</surname><given-names>JE</given-names></name>, <name><surname>Harel</surname><given-names>T</given-names></name>, <name><surname>Liu</surname><given-names>P</given-names></name>, <etal></etal>
<article-title>Resolution of Disease Phenotypes Resulting from Multilocus Genomic Variation</article-title>. <source/>N. Engl. J. Med
<month>1</month>
<day>05</day>
<year>2017</year>;<volume>376</volume>(<issue>1</issue>):<fpage>21</fpage>–<lpage>31</lpage>.<pub-id pub-id-type="pmid">27959697</pub-id></mixed-citation>
</ref>
<ref id="R24">
<label>24.</label>
<mixed-citation publication-type="journal"><name><surname>Pehlivan</surname><given-names>D</given-names></name>, <name><surname>Erdin</surname><given-names>S</given-names></name>, <name><surname>Carvalho</surname><given-names>CMB</given-names></name>, <etal></etal>
<article-title>Evidence implicating cohesin/condensin gene non-coding CNVs in the Cornelia de Lange</article-title>. <source/>Genomic Disorders 2012: The Genomics of Rare Diseases. <year>2012</year>.</mixed-citation>
</ref>
<ref id="R25">
<label>25.</label>
<mixed-citation publication-type="journal"><name><surname>Firth</surname><given-names>HV</given-names></name>, <name><surname>Richards</surname><given-names>SM</given-names></name>, <name><surname>Bevan</surname><given-names>AP</given-names></name>, <etal></etal>
<article-title>DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources</article-title>. <source/>Am. J. Hum. Genet
<month>4</month>
<year>2009</year>;<volume>84</volume>(<issue>4</issue>):<fpage>524</fpage>–<lpage>533</lpage>.<pub-id pub-id-type="pmid">19344873</pub-id></mixed-citation>
</ref>
<ref id="R26">
<label>26.</label>
<mixed-citation publication-type="journal"><name><surname>Kline</surname><given-names>AD</given-names></name>, <name><surname>Krantz</surname><given-names>ID</given-names></name>, <name><surname>Sommer</surname><given-names>A</given-names></name>, <etal></etal>
<article-title>Cornelia de Lange syndrome: clinical review, diagnostic and scoring systems, and anticipatory guidance</article-title>. <source/>Am. J. Med. Genet. A. <month>6</month>
<day>15</day>
<year>2007</year>;<volume>143A</volume>(<issue>12</issue>):<fpage>1287</fpage>–<lpage>1296</lpage>.<pub-id pub-id-type="pmid">17508425</pub-id></mixed-citation>
</ref>
<ref id="R27">
<label>27.</label>
<mixed-citation publication-type="journal"><name><surname>Solomon</surname><given-names>DA</given-names></name>, <name><surname>Kim</surname><given-names>JS</given-names></name>, <name><surname>Bondaruk</surname><given-names>J</given-names></name>, <etal></etal>
<article-title>Frequent truncating mutations of STAG2 in bladder cancer</article-title>. <source/>Nat. Genet
<month>12</month>
<year>2013</year>;<volume>45</volume>(<issue>12</issue>):<fpage>1428</fpage>–<lpage>1430</lpage>.<pub-id pub-id-type="pmid">24121789</pub-id></mixed-citation>
</ref>
<ref id="R28">
<label>28.</label>
<mixed-citation publication-type="journal"><name><surname>Solomon</surname><given-names>DA</given-names></name>, <name><surname>Kim</surname><given-names>T</given-names></name>, <name><surname>Diaz-Martinez</surname><given-names>LA</given-names></name>, <etal></etal>
<article-title>Mutational inactivation of STAG2 causes aneuploidy in human cancer</article-title>. <source/>Science. <month>8</month>
<day>19</day>
<year>2011</year>;<volume>333</volume>(<issue>6045</issue>):<fpage>1039</fpage>–<lpage>1043</lpage>.<pub-id pub-id-type="pmid">21852505</pub-id></mixed-citation>
</ref>
<ref id="R29">
<label>29.</label>
<mixed-citation publication-type="journal"><name><surname>Sofueva</surname><given-names>S</given-names></name>, <name><surname>Yaffe</surname><given-names>E</given-names></name>, <name><surname>Chan</surname><given-names>WC</given-names></name>, <etal></etal>
<article-title>Cohesin-mediated interactions organize chromosomal domain architecture</article-title>. <source/>EMBO J
<month>12</month>
<day>11</day>
<year>2013</year>;<volume>32</volume>(<issue>24</issue>):<fpage>3119</fpage>–<lpage>3129</lpage>.<pub-id pub-id-type="pmid">24185899</pub-id></mixed-citation>
</ref>
<ref id="R30">
<label>30.</label>
<mixed-citation publication-type="journal"><name><surname>Kagey</surname><given-names>MH</given-names></name>, <name><surname>Newman</surname><given-names>JJ</given-names></name>, <name><surname>Bilodeau</surname><given-names>S</given-names></name>, <etal></etal>
<article-title>Mediator and cohesin connect gene expression and chromatin architecture</article-title>. <source/>Nature. <month>9</month>
<day>23</day>
<year>2010</year>;<volume>467</volume>(<issue>7314</issue>):<fpage>430</fpage>–<lpage>435</lpage>.<pub-id pub-id-type="pmid">20720539</pub-id></mixed-citation>
</ref>
<ref id="R31">
<label>31.</label>
<mixed-citation publication-type="journal"><name><surname>Rubio</surname><given-names>ED</given-names></name>, <name><surname>Reiss</surname><given-names>DJ</given-names></name>, <name><surname>Welcsh</surname><given-names>PL</given-names></name>, <etal></etal>
<article-title>CTCF physically links cohesin to chromatin</article-title>. <source/>Proc. Natl. Acad. Sci. U. S. A
<month>6</month>
<day>17</day>
<year>2008</year>;<volume>105</volume>(<issue>24</issue>):<fpage>8309</fpage>–<lpage>8314</lpage>.<pub-id pub-id-type="pmid">18550811</pub-id></mixed-citation>
</ref>
<ref id="R32">
<label>32.</label>
<mixed-citation publication-type="journal"><name><surname>Allen</surname><given-names>BL</given-names></name>, <name><surname>Taatjes</surname><given-names>DJ</given-names></name>. <article-title>The Mediator complex: a central integrator of transcription</article-title>. <source/>Nat. Rev. Mol. Cell Biol
<month>3</month>
<year>2015</year>;<volume>16</volume>(<issue>3</issue>):<fpage>155</fpage>–<lpage>166</lpage>.<pub-id pub-id-type="pmid">25693131</pub-id></mixed-citation>
</ref>
<ref id="R33">
<label>33.</label>
<mixed-citation publication-type="journal"><name><surname>Strubbe</surname><given-names>G</given-names></name>, <name><surname>Popp</surname><given-names>C</given-names></name>, <name><surname>Schmidt</surname><given-names>A</given-names></name>, <etal></etal>
<article-title>Polycomb purification by in vivo biotinylation tagging reveals cohesin and Trithorax group proteins as interaction partners</article-title>. <source/>Proc. Natl. Acad. Sci. U. S. A
<month>4</month>
<day>05</day>
<year>2011</year>;<volume>108</volume>(<issue>14</issue>):<fpage>5572</fpage>–<lpage>5577</lpage>.<pub-id pub-id-type="pmid">21415365</pub-id></mixed-citation>
</ref>
<ref id="R34">
<label>34.</label>
<mixed-citation publication-type="journal"><name><surname>Izumi</surname><given-names>K</given-names></name>, <name><surname>Nakato</surname><given-names>R</given-names></name>, <name><surname>Zhang</surname><given-names>Z</given-names></name>, <etal></etal>
<article-title>Germline gain-of-function mutations in AFF4 cause a developmental syndrome functionally linking the super elongation complex and cohesin</article-title>. <source/>Nat. Genet
<month>4</month>
<year>2015</year>;<volume>47</volume>(<issue>4</issue>):<fpage>338</fpage>–<lpage>344</lpage>.<pub-id pub-id-type="pmid">25730767</pub-id></mixed-citation>
</ref>
<ref id="R35">
<label>35.</label>
<mixed-citation publication-type="journal"><name><surname>O’Rawe</surname><given-names>JA</given-names></name>, <name><surname>Wu</surname><given-names>Y</given-names></name>, <name><surname>Dorfel</surname><given-names>MJ</given-names></name>, <etal></etal>
<article-title>TAF1 Variants Are Associated with Dysmorphic Features, Intellectual Disability, and Neurological Manifestations</article-title>. <source/>Am. J. Hum. Genet
<month>12</month>
<day>03</day>
<year>2015</year>;<volume>97</volume>(<issue>6</issue>):<fpage>922</fpage>–<lpage>932</lpage>.<pub-id pub-id-type="pmid">26637982</pub-id></mixed-citation>
</ref>
<ref id="R36">
<label>36.</label>
<mixed-citation publication-type="journal"><name><surname>Parenti</surname><given-names>I</given-names></name>, <name><surname>Gervasini</surname><given-names>C</given-names></name>, <name><surname>Pozojevic</surname><given-names>J</given-names></name>, <etal></etal>
<article-title>Broadening of cohesinopathies: exome sequencing identifies mutations in ANKRD11 in two patients with Cornelia de Lange-overlapping phenotype</article-title>. <source/>Clin. Genet
<month>1</month>
<year>2016</year>;<volume>89</volume>(<issue>1</issue>):<fpage>74</fpage>–<lpage>81</lpage>.<pub-id pub-id-type="pmid">25652421</pub-id></mixed-citation>
</ref>
<ref id="R37">
<label>37.</label>
<mixed-citation publication-type="journal"><name><surname>Kumar</surname><given-names>R</given-names></name>, <name><surname>Corbett</surname><given-names>MA</given-names></name>, <name><surname>Van Bon</surname><given-names>BW</given-names></name>, <etal></etal>
<article-title>Increased STAG2 dosage defines a novel cohesinopathy with intellectual disability and behavioral problems</article-title>. <source/>Hum. Mol. Genet
<month>12</month>
<day>20</day>
<year>2015</year>;<volume>24</volume>(<issue>25</issue>):<fpage>7171</fpage>–<lpage>7181</lpage>.<pub-id pub-id-type="pmid">26443594</pub-id></mixed-citation>
</ref>
<ref id="R38">
<label>38.</label>
<mixed-citation publication-type="journal"><name><surname>Gillis</surname><given-names>LA</given-names></name>, <name><surname>McCallum</surname><given-names>J</given-names></name>, <name><surname>Kaur</surname><given-names>M</given-names></name>, <etal></etal>
<article-title>NIPBL mutational analysis in 120 individuals with Cornelia de Lange syndrome and evaluation of genotype-phenotype correlations</article-title>. <source/>Am. J. Hum. Genet
<month>10</month>
<year>2004</year>;<volume>75</volume>(<issue>4</issue>):<fpage>610</fpage>–<lpage>623</lpage>.<pub-id pub-id-type="pmid">15318302</pub-id></mixed-citation>
</ref>
<ref id="R39">
<label>39.</label>
<mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>J</given-names></name>, <name><surname>Feldman</surname><given-names>R</given-names></name>, <name><surname>Zhang</surname><given-names>Z</given-names></name>, <etal></etal>
<article-title>SMC1A expression and mechanism of pathogenicity in probands with X-Linked Cornelia de Lange syndrome</article-title>. <source/>Hum. Mutat
<month>11</month>
<year>2009</year>;<volume>30</volume>(<issue>11</issue>):<fpage>1535</fpage>–<lpage>1542</lpage>.<pub-id pub-id-type="pmid">19701948</pub-id></mixed-citation>
</ref>
<ref id="R40">
<label>40.</label>
<mixed-citation publication-type="journal"><name><surname>Goldstein</surname><given-names>JH</given-names></name>, <name><surname>Tim-Aroon</surname><given-names>T</given-names></name>, <name><surname>Shieh</surname><given-names>J</given-names></name>, <etal></etal>
<article-title>Novel SMC1A frameshift mutations in children with developmental delay and epilepsy</article-title>. <source/>Eur. J. Med. Genet
<month>10</month>
<year>2015</year>;<volume>58</volume>(<issue>10</issue>):<fpage>562</fpage>–<lpage>568</lpage>.<pub-id pub-id-type="pmid">26386245</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="F1" orientation="portrait" position="float">
<label>Figure 1.</label>
<caption>
<p id="P45">Cohesin complex and its underlying genetic variants. <bold>A.</bold> Schematic diagram of the cohesin complex. The components are represented in different color shapes labeled with protein names. <bold>B.</bold> Comparison of genic distributions between our clinical exome cohort and two phenotype-driven cohorts of clinically diagnosed CdLS patients (from ref. <xref ref-type="bibr" rid="R19">19</xref> and BHCMG, respectively) <sup><xref ref-type="bibr" rid="R19">19</xref></sup>. Y-axis, proportion of molecular diagnosis provided by variants in each gene; x-axis, genes; black, patients without CdLS listed as differential diagnosis; dark grey, patients with CdLS as one of the differential diagnoses; grey, CdLS cohort from ref. <xref ref-type="bibr" rid="R19">19</xref>; light grey, CdLS cohort from BHCMG. <bold>C.</bold> Comparison of genic variant frequencies between COSMIC and ExAC cohorts. Filled circles represent comparison between frequencies of putative LoF variants between COSMIC and ExAC; open circles represent comparison between frequencies of missense variants between COSMIC and ExAC. Y-axis, ratio bewteen frequencies of genic variants (missense or putative LoF) in COSMIC and ExAC; x-axis, genes.</p>
</caption>
<graphic xlink:href="nihms-973104-f0001"></graphic>
</fig>
<fig id="F2" orientation="portrait" position="float">
<label>Figure 2.</label>
<caption>
<p id="P46">The variants in <italic>STAG1</italic> and <italic>STAG2</italic>. <bold>A.</bold> SNVs/indels in <italic>STAG1</italic>. <bold>B.</bold> SNVs/indels and one CNV deletion in <italic>STAG2.</italic> For panels A and B, the white segment represents the full-length protein, and the black segments represent protein domains; the missense variants are annotated above the segment, while the putative LoF variants (including the CNVs deletion in <italic>STAG2</italic>) are underneath; the variants colored in red are reported in the current study. The boxed variant (p.A638Vfs*10) in panel B is reported as a research variant. <bold>C.</bold> Diagram showing the CNV deletions overlapping <italic>STAG1</italic> reported in the DECIPHER and current study. The red segments represent the deletions, which are divided in two groups of “DECIPHER” and “Current Study”. The bottom panel shows genes in the region. <italic>STAG1</italic> is highlighted in red. <bold>D.</bold> Photographs showing the front and side facial profiles of Patients 8 and 9 with <italic>de novo</italic> variant in <italic>STAG2</italic>. The patient numbers and variants are listed under the photograph.</p>
</caption>
<graphic xlink:href="nihms-973104-f0002"></graphic>
</fig>
<table-wrap id="T1" orientation="landscape" position="float">
<label>Table 1.</label>
<caption>
<p id="P47">Summary of variants in the known CdLS genes identified by Baylor Genetics clinical exome sequencing.</p>
</caption>
<table frame="box" rules="all">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Gene (Transcript)</th>
<th align="left" colspan="1" rowspan="1" valign="top">Genomic coordinates (hg19)</th>
<th align="left" colspan="1" rowspan="1" valign="top">Exon/Intron</th>
<th align="left" colspan="1" rowspan="1" valign="top">Coding sequence change</th>
<th align="left" colspan="1" rowspan="1" valign="top">Protein change</th>
<th align="left" colspan="1" rowspan="1" valign="top">Zygosity</th>
<th align="left" colspan="1" rowspan="1" valign="top">Inheritance</th>
<th align="left" colspan="1" rowspan="1" valign="top">Novelty</th>
<th align="left" colspan="1" rowspan="1" valign="top">Classification <sup><xref ref-type="table-fn" rid="TFN3">c</xref></sup></th>
<th align="left" colspan="1" rowspan="1" valign="top">CdLS as a differential diagnosis?</th>
<th align="left" colspan="1" rowspan="1" valign="top">Dual molecular diagnosis?</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="5" valign="top"><italic>NIPBL</italic> (NM_133433.3)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chr5: 36985760</td>
<td align="left" colspan="1" rowspan="1" valign="top">exon10</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.2479_2480del</td>
<td align="left" colspan="1" rowspan="1" valign="top">p.R827Gfs*2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Het</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reported <sup><xref ref-type="bibr" rid="R38">38</xref></sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">P</td>
<td align="left" colspan="1" rowspan="1" valign="top">no (prenatal)</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Chr5: 37017173</td>
<td align="left" colspan="1" rowspan="1" valign="top">exon24</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.4829T&gt;C</td>
<td align="left" colspan="1" rowspan="1" valign="top">p.L1610P</td>
<td align="left" colspan="1" rowspan="1" valign="top">Het</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">This cohort</td>
<td align="left" colspan="1" rowspan="1" valign="top">LP</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Chr5: 37046239</td>
<td align="left" colspan="1" rowspan="1" valign="top">exon38</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.6527T&gt;C</td>
<td align="left" colspan="1" rowspan="1" valign="top">p.L2176P</td>
<td align="left" colspan="1" rowspan="1" valign="top">Het</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">This cohort</td>
<td align="left" colspan="1" rowspan="1" valign="top">LP</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Chr5: 37052580</td>
<td align="left" colspan="1" rowspan="1" valign="top">exon42</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.7175G&gt;A</td>
<td align="left" colspan="1" rowspan="1" valign="top">p.C2392Y</td>
<td align="left" colspan="1" rowspan="1" valign="top">Het</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">This cohort</td>
<td align="left" colspan="1" rowspan="1" valign="top">LP</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Chr5: 36962223</td>
<td align="left" colspan="1" rowspan="1" valign="top">intron5</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.459-2A&gt;G</td>
<td align="left" colspan="1" rowspan="1" valign="top">splicing</td>
<td align="left" colspan="1" rowspan="1" valign="top">Het</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">This cohort</td>
<td align="left" colspan="1" rowspan="1" valign="top">P</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes, among others, POC <sup><xref ref-type="table-fn" rid="TFN4">d</xref></sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="14" valign="top"><italic>SMC1A</italic> (NM_006306.2)</td>
<td align="left" colspan="1" rowspan="1" valign="top">ChrX: 53442118</td>
<td align="left" colspan="1" rowspan="1" valign="top">exon2</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.G110T</td>
<td align="left" colspan="1" rowspan="1" valign="top">p.G37V</td>
<td align="left" colspan="1" rowspan="1" valign="top">Het</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">This cohort</td>
<td align="left" colspan="1" rowspan="1" valign="top">LP</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ChrX: 53442112</td>
<td align="left" colspan="1" rowspan="1" valign="top">exon2</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.116C&gt;G</td>
<td align="left" colspan="1" rowspan="1" valign="top">p.S39*</td>
<td align="left" colspan="1" rowspan="1" valign="top">Het</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">This cohort</td>
<td align="left" colspan="1" rowspan="1" valign="top">P</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>MYH2</italic> heterozygous c.1160C&gt;T (p.A387V), <italic>de novo</italic></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ChrX: 53442100</td>
<td align="left" colspan="1" rowspan="1" valign="top">exon2</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.128A&gt;T</td>
<td align="left" colspan="1" rowspan="1" valign="top">p.D43V</td>
<td align="left" colspan="1" rowspan="1" valign="top">Het</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">This cohort</td>
<td align="left" colspan="1" rowspan="1" valign="top">LP</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ChrX: 53442088</td>
<td align="left" colspan="1" rowspan="1" valign="top">exon2</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.140T&gt;G</td>
<td align="left" colspan="1" rowspan="1" valign="top">p.F47C</td>
<td align="left" colspan="1" rowspan="1" valign="top">Het</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">This cohort</td>
<td align="left" colspan="1" rowspan="1" valign="top">LP</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>CFTR</italic> homozygous c.1521_1523del (p.F508del)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ChrX: 53441930</td>
<td align="left" colspan="1" rowspan="1" valign="top">exon2</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.298G&gt;C</td>
<td align="left" colspan="1" rowspan="1" valign="top">p.G100R</td>
<td align="left" colspan="1" rowspan="1" valign="top">Het</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">This cohort</td>
<td align="left" colspan="1" rowspan="1" valign="top">LP</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>EFHC1</italic> heterozygous c.1612C&gt;T (p.R538X), paternally inherited</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ChrX: 53440211</td>
<td align="left" colspan="1" rowspan="1" valign="top">exon4</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.586C&gt;T</td>
<td align="left" colspan="1" rowspan="1" valign="top">p.R196C</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hem</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">This cohort</td>
<td align="left" colspan="1" rowspan="1" valign="top">LP</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>DMD</italic> hemizygous deletion exons 49-51, maternally inherited</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ChrX: 53440048</td>
<td align="left" colspan="1" rowspan="1" valign="top">exon5</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.655del</td>
<td align="left" colspan="1" rowspan="1" valign="top">p.A219Lfs*45</td>
<td align="left" colspan="1" rowspan="1" valign="top">Het</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">This cohort</td>
<td align="left" colspan="1" rowspan="1" valign="top">P</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ChrX: 53439899</td>
<td align="left" colspan="1" rowspan="1" valign="top">exon5</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.802_804del</td>
<td align="left" colspan="1" rowspan="1" valign="top">p.K268del</td>
<td align="left" colspan="1" rowspan="1" valign="top">Het</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reported <sup><xref ref-type="bibr" rid="R39">39</xref></sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">P</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ChrX: 53436051</td>
<td align="left" colspan="1" rowspan="1" valign="top">exon9</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.1487G&gt;A</td>
<td align="left" colspan="1" rowspan="1" valign="top">p.R496H</td>
<td align="left" colspan="1" rowspan="1" valign="top">Het</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reported <sup><xref ref-type="bibr" rid="R8">8</xref></sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">P</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ChrX: 53430523</td>
<td align="left" colspan="1" rowspan="1" valign="top">exon15</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.2394dup</td>
<td align="left" colspan="1" rowspan="1" valign="top">p.R799Tfs*4</td>
<td align="left" colspan="1" rowspan="1" valign="top">Het</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">This cohort</td>
<td align="left" colspan="1" rowspan="1" valign="top">P</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ChrX: 53430498</td>
<td align="left" colspan="1" rowspan="1" valign="top">exon15</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.2420G&gt;A</td>
<td align="left" colspan="1" rowspan="1" valign="top">p.R807H</td>
<td align="left" colspan="1" rowspan="1" valign="top">Het</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">This cohort</td>
<td align="left" colspan="1" rowspan="1" valign="top">LP</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ChrX: 53426525</td>
<td align="left" colspan="1" rowspan="1" valign="top">exon16</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.2547del</td>
<td align="left" colspan="1" rowspan="1" valign="top">p.I849Mfs*12</td>
<td align="left" colspan="1" rowspan="1" valign="top">Het</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">This cohort</td>
<td align="left" colspan="1" rowspan="1" valign="top">P</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ChrX: 53423152</td>
<td align="left" colspan="1" rowspan="1" valign="top">exon18</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.2853_2856del</td>
<td align="left" colspan="1" rowspan="1" valign="top">p.S951Rfs*12</td>
<td align="left" colspan="1" rowspan="1" valign="top">Het</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reported <sup><xref ref-type="bibr" rid="R40">40</xref></sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">P</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ChrX: 53438853</td>
<td align="left" colspan="1" rowspan="1" valign="top">intron7</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.1114-2A&gt;G</td>
<td align="left" colspan="1" rowspan="1" valign="top">splicing</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hem</td>
<td align="left" colspan="1" rowspan="1" valign="top">Maternal <sup><xref ref-type="table-fn" rid="TFN1">a</xref></sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">This cohort</td>
<td align="left" colspan="1" rowspan="1" valign="top">P</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="4" valign="top"><italic>SMC3</italic> (NM_005445.3)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chr10: 112341720</td>
<td align="left" colspan="1" rowspan="1" valign="top">exon9</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.587T&gt;C</td>
<td align="left" colspan="1" rowspan="1" valign="top">p.I196T</td>
<td align="left" colspan="1" rowspan="1" valign="top">Het</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">This cohort</td>
<td align="left" colspan="1" rowspan="1" valign="top">LP</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Chr10: 112349688</td>
<td align="left" colspan="1" rowspan="1" valign="top">exon15</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.1453_1455del</td>
<td align="left" colspan="1" rowspan="1" valign="top">p.A485del</td>
<td align="left" colspan="1" rowspan="1" valign="top">Het</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">This cohort</td>
<td align="left" colspan="1" rowspan="1" valign="top">LP</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Chr10: 112356303</td>
<td align="left" colspan="1" rowspan="1" valign="top">exon19</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.2111T&gt;C</td>
<td align="left" colspan="1" rowspan="1" valign="top">p.I704T</td>
<td align="left" colspan="1" rowspan="1" valign="top">Het</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">This cohort</td>
<td align="left" colspan="1" rowspan="1" valign="top">LP</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Chr10: 112362647</td>
<td align="left" colspan="1" rowspan="1" valign="top">exon27</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.3362C&gt;T</td>
<td align="left" colspan="1" rowspan="1" valign="top">p.S1121F</td>
<td align="left" colspan="1" rowspan="1" valign="top">Het</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">This cohort</td>
<td align="left" colspan="1" rowspan="1" valign="top">LP</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>CREBBP</italic> heterozygous c.6137C&gt;T (p.A2046V), <italic>de novo</italic></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" valign="top"><italic>RAD21</italic> (NM_006265.2)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chr8: 117862926</td>
<td align="left" colspan="1" rowspan="1" valign="top">exon12</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.1550dupC</td>
<td align="left" colspan="1" rowspan="1" valign="top">p.E518fs</td>
<td align="left" colspan="1" rowspan="1" valign="top">Het</td>
<td align="left" colspan="1" rowspan="1" valign="top">Paternal <sup><xref ref-type="table-fn" rid="TFN1">a</xref></sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">This cohort</td>
<td align="left" colspan="1" rowspan="1" valign="top">P</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Chr8: 117866483</td>
<td align="left" colspan="1" rowspan="1" valign="top">intron10</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.1161+1G&gt;A</td>
<td align="left" colspan="1" rowspan="1" valign="top">splicing</td>
<td align="left" colspan="1" rowspan="1" valign="top">Het</td>
<td align="left" colspan="1" rowspan="1" valign="top">Maternal <sup><xref ref-type="table-fn" rid="TFN1">a</xref></sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">This cohort</td>
<td align="left" colspan="1" rowspan="1" valign="top">P</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="8" valign="top"><italic>HDAC8</italic> (NM_018486.2)</td>
<td align="left" colspan="1" rowspan="1" valign="top">ChrX: 71787758</td>
<td align="left" colspan="1" rowspan="1" valign="top">exon4</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.418G&gt;A</td>
<td align="left" colspan="1" rowspan="1" valign="top">p.G140R</td>
<td align="left" colspan="1" rowspan="1" valign="top">Het</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">This cohort</td>
<td align="left" colspan="1" rowspan="1" valign="top">LP</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ChrX: 71715066</td>
<td align="left" colspan="1" rowspan="1" valign="top">exon5</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.490C&gt;T</td>
<td align="left" colspan="1" rowspan="1" valign="top">p.R164* <sup><xref ref-type="table-fn" rid="TFN2">b</xref></sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">Het</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reported <sup><xref ref-type="bibr" rid="R7">7</xref></sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">P</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ChrX: 71715066</td>
<td align="left" colspan="1" rowspan="1" valign="top">exon5</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.490C&gt;T</td>
<td align="left" colspan="1" rowspan="1" valign="top">p.R164* <sup><xref ref-type="table-fn" rid="TFN2">b</xref></sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">Het</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reported <sup><xref ref-type="bibr" rid="R7">7</xref></sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">P</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ChrX: 71715029</td>
<td align="left" colspan="1" rowspan="1" valign="top">exon5</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.527A&gt;G</td>
<td align="left" colspan="1" rowspan="1" valign="top">p.D176G</td>
<td align="left" colspan="1" rowspan="1" valign="top">Het</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">This cohort</td>
<td align="left" colspan="1" rowspan="1" valign="top">LP</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>IRX5</italic> compound heterozygous c.1362_1368delinsGT (p.K455fs) and c.240_242delCTC (p.S81del)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ChrX: 71710823</td>
<td align="left" colspan="1" rowspan="1" valign="top">exon6</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.584T&gt;A</td>
<td align="left" colspan="1" rowspan="1" valign="top">p.V195D</td>
<td align="left" colspan="1" rowspan="1" valign="top">Het</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">This cohort</td>
<td align="left" colspan="1" rowspan="1" valign="top">LP</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ChrX: 71684526</td>
<td align="left" colspan="1" rowspan="1" valign="top">exon8</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.793G&gt;A</td>
<td align="left" colspan="1" rowspan="1" valign="top">p.G265R</td>
<td align="left" colspan="1" rowspan="1" valign="top">Het</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">This cohort</td>
<td align="left" colspan="1" rowspan="1" valign="top">LP</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ChrX: 71681927</td>
<td align="left" colspan="1" rowspan="1" valign="top">exon9</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.932C&gt;T</td>
<td align="left" colspan="1" rowspan="1" valign="top">p.T311M</td>
<td align="left" colspan="1" rowspan="1" valign="top">Het</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reported <sup><xref ref-type="bibr" rid="R7">7</xref></sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">P</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ChrX: 71681922</td>
<td align="left" colspan="1" rowspan="1" valign="top">exon9</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.937C&gt;T</td>
<td align="left" colspan="1" rowspan="1" valign="top">p.R313*</td>
<td align="left" colspan="1" rowspan="1" valign="top">Het</td>
<td align="left" colspan="1" rowspan="1" valign="top">Not maternal</td>
<td align="left" colspan="1" rowspan="1" valign="top">This cohort</td>
<td align="left" colspan="1" rowspan="1" valign="top">P</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TFN1">
<label>a</label>
<p id="P48">Inherited variants from mildly affected parents, who were confirmed to be non-mosaic by Sanger sequencing (data not shown);</p>
</fn>
<fn id="TFN2">
<label>b</label>
<p id="P49">Identical pathogenic variants in unrelated patients;</p>
</fn>
<fn id="TFN3">
<label>c</label>
<p id="P50">classifications include pathogenic (P) and likely pathogenic (LP);</p>
</fn>
<fn id="TFN4">
<label>d</label>
<p id="P51">POC, product of conception</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T2" orientation="landscape" position="float">
<label>Table 2.</label>
<caption>
<p id="P52">Genotypes and phenotypes of patients with SNVs/indels in <italic>STAG1, STAG2</italic> and <italic>PDS5A</italic> identified in current study.</p>
</caption>
<table frame="box" rules="all">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="2" rowspan="1" valign="top">Genes</th>
<th align="left" colspan="4" rowspan="1" valign="top">STAG1 <break></break>(NM_005862.2)</th>
<th align="left" colspan="6" rowspan="1" valign="top">STAG2 <break></break>(NM_006603.4)</th>
<th align="left" colspan="1" rowspan="1" valign="top">PDS5A <break></break>(NM_001100399.1)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="2" rowspan="1" valign="top">
<bold>Patients</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Patient 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Patient 2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Patient 3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reported in Ref. <xref ref-type="bibr" rid="R13">13</xref> (n=17)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Patient 7</td>
<td align="left" colspan="1" rowspan="1" valign="top">Patient 8</td>
<td align="left" colspan="1" rowspan="1" valign="top">Patient 9</td>
<td align="left" colspan="1" rowspan="1" valign="top">Patient 10</td>
<td align="left" colspan="1" rowspan="1" valign="top">Patient 11</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reported in Ref <xref ref-type="bibr" rid="R14">14</xref> (n=1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Patient 13</td>
</tr>
<tr>
<td align="left" colspan="2" rowspan="1" valign="top">
<bold>Age at last exam</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">11 yr 5 mo</td>
<td align="left" colspan="1" rowspan="1" valign="top">4 yr 8 mo</td>
<td align="left" colspan="1" rowspan="1" valign="top">4 yr 2 mo</td>
<td align="left" colspan="1" rowspan="1" valign="top">30 mo to 33 yr (median 7 yr)</td>
<td align="left" colspan="1" rowspan="1" valign="top">3 yr 8 mo</td>
<td align="left" colspan="1" rowspan="1" valign="top">4 yr 6 mo</td>
<td align="left" colspan="1" rowspan="1" valign="top">11 yr 1 mo</td>
<td align="left" colspan="1" rowspan="1" valign="top">1 yr 11 mo</td>
<td align="left" colspan="1" rowspan="1" valign="top">5 yr 3 mo</td>
<td align="left" colspan="1" rowspan="1" valign="top">8 yr</td>
<td align="left" colspan="1" rowspan="1" valign="top">2 yr 6 mo</td>
</tr>
<tr>
<td align="left" colspan="2" rowspan="1" valign="top">
<bold>Variant</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.2009_2012del <break></break>(p.N670Ifs*25)</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.1129C&gt;T <break></break>(p.R377C)</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.253G&gt;A (p.V85I): <italic>STAG1</italic>
<break></break>c.1720-2A&gt;G : <italic>ASXL1</italic>;</td>
<td align="left" colspan="1" rowspan="1" valign="top">CNV deletion <break></break>or SNVs/indels</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.418C&gt;T <break></break>(p.Q140*)</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.1605T&gt;A <break></break>(p.C535*)</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.1811G&gt;A <break></break>(p.R604Q)</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.1658_1660delinsT <break></break>(p.K553Ifs*6)</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.476A&gt;G (p.Y159C), <break></break>hemizygous</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.205C&gt;T <break></break>p.(Arg69*)</td>
<td align="left" colspan="1" rowspan="1" valign="top">c.2275G&gt;T (p.E759*): <italic>PDS5A</italic>
<break></break>c.3325A&gt;T (p.K1109*): <italic>ASXL3</italic>;</td>
</tr>
<tr>
<td align="left" colspan="2" rowspan="1" valign="top">
<bold>Critical gene(s)</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>STAG1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>STAG1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ASXL1, STAG1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>STAG1</italic> and others<sup><xref ref-type="table-fn" rid="TFN6">a</xref></sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>STAG2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>STAG2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>STAG2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>STAG2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>STAG2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>STAG2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ASXL3, PDS5A</italic>
</td>
</tr>
<tr>
<td align="left" colspan="2" rowspan="1" valign="top">
<bold>Gender</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">F</td>
<td align="left" colspan="1" rowspan="1" valign="top">M</td>
<td align="left" colspan="1" rowspan="1" valign="top">F</td>
<td align="left" colspan="1" rowspan="1" valign="top">9M/8F</td>
<td align="left" colspan="1" rowspan="1" valign="top">F</td>
<td align="left" colspan="1" rowspan="1" valign="top">F</td>
<td align="left" colspan="1" rowspan="1" valign="top">F</td>
<td align="left" colspan="1" rowspan="1" valign="top">F</td>
<td align="left" colspan="1" rowspan="1" valign="top">M</td>
<td align="left" colspan="1" rowspan="1" valign="top">F</td>
<td align="left" colspan="1" rowspan="1" valign="top">F</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Inheritance</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">both <italic>de novo</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>de novo</italic> or inherited</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>de novo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>ASXL3</italic>: <italic>de novo</italic>; <italic>PDS5A</italic>: paternal</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="4" valign="top">
<bold>Growth</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>IUGR</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">3/17</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Failure to thrive</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/17</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Short stature</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">5/17</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Microcephaly</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">4/17</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="3" valign="top">
<bold>Development</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Intellectual disability</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">17/17, mild to severe</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Developmental Delay</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">17/17</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Autism Spectrum Disorder</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">7/17</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="4" valign="top">
<bold>Neuro-behavioral</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Behavioral problems</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+,irritability</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Seizures</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+, during infancy</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">7/17 with epilepsy</td>
<td align="left" colspan="1" rowspan="1" valign="top">Myoclonic movements</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Hypertonia</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Hypotonia</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">4/17</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="15" valign="top">
<bold>Craniofacial features</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Brachycephaly</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="15" valign="top">micrognathia, ear abnormalities, wide-set eyes, beaked or prominent nose, arched eyebrows, or low-set ears, cleft/arched palate</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Long curly eyelashes</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="13" valign="top">facial features included 14/17 with deep-set eyes, 13/17 with wide mouth, 7/17 with high nasal bridge, 8/17 with thin eyebrows, 4/17 with widely spaced central incisors</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Synophrys</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Anteverted nares</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Depressed/broad nasal bridge</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Bulbous nasal tip</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Low-set ears</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Dysmorphic ears</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Long/smooth philtrum</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>High arched palate</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+, narrow</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Thin upper lip</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Downturned mouth</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−,small</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Cleft lip/palate</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Widely spaced teeth</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Micrognathia</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="4" valign="top">
<bold>Skin, Nails, Hair</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Hypoplastic nails</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+, with pits</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Hirsutism</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Hairline</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">low, posterior</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">low, anterior</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Cutis marmorata</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">+,significant</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Ocular</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Strabismus</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+, exotropia</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Otolaryngologic</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Hearing loss</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+,conductive</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Cardiovascular</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Congenital heart defect</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">PDA</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">1/17</td>
<td align="left" colspan="1" rowspan="1" valign="top">+, Hypoplastic left heart, VSD, CA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR, no murmur</td>
<td align="left" colspan="1" rowspan="1" valign="top">Minimal PFO, normal on follow-up</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" valign="top">
<bold>Respiratory/Thorax</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Congenital diaphragmatic hernia</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+, right</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Pulmonary hypoplasia</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+, right</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Gastrointestinal</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Gastroesophageal reflux</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">9/17</td>
<td align="left" colspan="1" rowspan="1" valign="top">+, Nissen and G-tube</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="3" valign="top">
<bold>Genitourinary/Renal Anomaly</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Hypoplastic male genitalia</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Cryptorchidism</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">+, left</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">2/9</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Structural anomalies of the renal tract</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">+, horseshoe kidney</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR, not examined</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">+, Single kidney</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="8" valign="top">
<bold>Musculoskeletal/Extremities</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Scoliosis</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">2/17</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Rib fusion</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+, T4-5, T10-11, BL</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Vertebral anomalies</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+, vertebral clefts</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+, vertebral clefts</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Arm /hand anomalies</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Limited elbow extension</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Fifth finger clinodactyly</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Single transverse palmar crease</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>2-3 toe syndactyly</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" valign="top">
<bold>Studies and imaging</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Abnormal Brain MRI</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">3/17 showed atrophy; other 3/17 showed unspecific anomaly</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ectopic posterior pituitary, short pituitary stalk</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+,mild</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Abnormal echocardiogram</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">−</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
<td align="left" colspan="1" rowspan="1" valign="top">+</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TFN5">
<p id="P53">(BL bilateral; mo – months; yr-years; CA: coarctation of the aorta; IUGR - Intrauterine growth retardation; NA- not applicable; NR - no record; PDA- patent ductus arteriosus; PS - pulmonic stenosis; VSD - ventricular septal defect; PFO - patent foramen ovale)</p>
</fn>
<fn id="TFN6">
<label>a</label>
<p id="P54"><italic>STAG1</italic> was affected by both CNV deletion and SNVs/indels. The deletions included 3 <italic>de novo</italic> and 1 unknown which encompassed <italic>STAG1</italic> and <italic>PCCB</italic>, 1 intragenic which was absent in the mother, and 2 intragenic which were maternally inherited; the SNVs/indels included 8 <italic>de novo</italic> missense and 2 <italic>de novo</italic> frameshift variants of <italic>STAG1</italic>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>
</pmc-articleset>